2003

AHFC Receives $731,172 in Federal Homeless Grants: PRNewswire - December 31, 2003; ANCHORAGE, Dec. 31 /PRNewswire/ -- Alaska Housing Finance Corporation (AHFC) will receive a total of $731,172 from the U.S. Department of Housing & Urban Development (HUD). Two renewal grant awards will continue the Shelter+Care program started in Anchorage in 1996. The funds are passed through to AHFC s project sp
Trinity Biotech Receives FDA Approval for Uni-Gold Recombigen(TM) HIV Test: PRNewswire - December 29, 2003; DUBLIN, Ireland , Dec. 29 /PRNewswire-FirstCall/ -- Trinity Biotech plc (Nasdaq: TRIB) today announced that it has received approval from the U.S. Food and Drug Administration ( FDA ) to market its Uni-Gold Recombigen(TM) HIV test in the United States .
Medical Services to Begin Last Phase of Testing in the United States: PRNewswire - December 29, 2003; EDMONTON, Alberta, Dec. 29 /PRNewswire-FirstCall/ -- Medical Services International Inc., (Pinksheets: MSITF) is pleased to announce that it has entered the final phase of testing required to submit its application for approval of the VScan HIV 1&2 rapid test kit. The company anticipates completing the final phase
Gen-Probe Receives FDA Approval for STD Testing on the TIGRIS(R) DTS(TM) System, First Fully Automated, Amplified Molecular Diagnostic Testing Instrument - Innovative System Designed to Improve Workflow and Increase Productivity for Clinical Laboratories: PRNewswire - December 29, 2003; SAN DIEGO, Dec. 29 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the U.S. Food and Drug Administration ( FDA ) has granted marketing clearance for sexually transmitted disease testing on the company s TIGRIS(R) DTS(TM) System, the first fully automated, high throughput instrument
AIDS Healthcare Foundation, California Medical Association & Others Stop Illegal Funding Cuts to Medical Providers Treating California Medicaid Patients: PRNewswire - December 23, 2003; -- California Medi-Cal Program Enjoined From Cutting $115M in Health Insurance Benefits to Indigent Patients -- AHF Will Appeal Decision on Cuts to Medi-Cal Managed Care LOS ANGELES, Dec. 23 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), the largest AIDS organization in the US and operator of free AIDS treatment cli
CytRx Announces Plans for Filing of Investigational New Drug Application for HIV Vaccine and Strategic Alliance With Advanced BioScience Laboratories: PRNewswire - December 23, 2003; LOS ANGELES, Dec. 23 /PRNewswire-FirstCall/ -- CytRx Corporation (Nasdaq: CYTR) and Advanced BioScience Laboratories (ABL) announced today plans for filing of an Investigational New Drug Application (IND) with the Food and Drug Administration ( FDA ) for a Phase I clinical trial for a new DNA-based HIV vaccine, and a n
Oprah Winfrey's Visit to South Africa Prompts Viewers to Help Children Orphaned by HIV/AIDS: UNICEF Applauds Oprah for her Efforts to Alert Americans: PRNewswire - December 22, 2003; NEW YORK, Dec. 22 /PRNewswire/ -- Having witnessed on national television Oprah Winfrey s personal commitment to raising awareness of the global AIDS pandemic, thousands of newly inspired Americans have contacted the U.S. Fund for UNICEF so that they too can help millions of children in Africa who have been orphaned by
VIRxSYS' DSMB Recommends Continuation of Its Phase I Clinical Trial: The Clinical Trial is First-ever to Use Lentiviral Vectors for Gene Therapy In Humans: PRNewswire - December 18, 2003; GAITHERSBURG, Md., Dec. 18 /PRNewswire/ -- VIRxSYS Corporation, a private biotechnology company focused on the development of genetic medicines for the treatment of serious diseases such as HIV/AIDS, announced today that a third patient will be treated in its Phase I trial with VRX496 modified T cells. An independent D
Realistic Drama on African American Gays and HIV Now Available: PRNewswire - December 18, 2003; CHICAGO, Dec. 18 /PRNewswire/ -- Health departments and community organizations wondering what to do for Kwanzaa (December) or Black History Month (February) can now consider the long-awaited sequel to an award-winning drama. Kevin s Room 2: Trust is a groundbreaking new film that addresses the spread of HIV among gay
Roche and Trimeris Submit 48-Week Data to U.S. FDA for Full Approval of FUZEON(R), First and Only HIV Fusion Inhibitor: PRNewswire - December 16, 2003; NUTLEY, N.J. and DURHAM, N.C., Dec. 16 /PRNewswire-FirstCall/ -- Roche and Trimeris, Inc. (Nasdaq: TRMS) today announced submission of 48-week efficacy and safety data from two pivotal studies of FUZEON(R) to the U.S. Food and Drug Administration ( FDA ) to support its full, or traditional, approval. The data demonstr
AIDS Healthcare Foundation Criticizes Abbott Labs for increasing Price from Roughly $250 per Bottle to Nearly $1200: PRNewswire - December 16, 2003; LOS ANGELES -- AIDS Healthcare Foundation (AHF), the largest AIDS organization in the US which operates clinics in the US, Africa and Central America, today criticized Abbott Labs for their recent five-fold price increase on their key protease inhibitor, Norvir (R), effective December 3, 2003. Abbott has instit
Social Marketers Join Faith Groups to Fight AIDS: PRNewswire - December 15, 2003; WASHINGTON, Dec. 15 /PRNewswire/ -- A nonprofit social marketing organization that promotes abstinence, fidelity and correct and consistent condom use has launched a global initiative in Africa to scale up its collaboration with faith-based organizations (FBOs) in developing countries to fight HIV/AIDS more effectively
Medical Services Obtains Excellent Test Results in Clinical Testing in China: PRNewswire - December 15, 2003; EDMONTON, Alberta, Dec. 15 /PRNewswire-FirstCall/ -- Medical Services International Inc., (Pinksheets: MSITF) is pleased to announce that it has received the preliminary testing results related to its SDA application in The Peoples Republic of China . The results of the clinical testing showed that the VScan HIV test k
AIDS Healthcare Foundation Decries GSK CEO Salary: PRNewswire - December 14, 2003; LOS ANGELES, Dec. 14 /PRNewswire/ -- AIDS Healthcare Foundation released the following statement today in response to news reports of AIDS pharmaceutical giant GlaxoSmithKline s decision to pay its chief executive an annual $10 million: This announcement continues GSK s tradition of bad decision-making on corporate com
BET Launches Rap-It-Up Short Film Competition: Submitted Entries Must Focus on HIV-Related Topics, African-American Themes; BET to Produce and Televise Winning Selections in June 2004: PRNewswire - December 11, 2003; WASHINGTON, Dec. 11 /PRNewswire/ -- BET announced today plans for its inaugural Rap-It-Up Short Film Competition in partnership with The Black AIDS Institute and the Henry J. Kaiser Family Foundation. The purpose of the competition is to highlight the issue of HIV/AIDS, HIV prevention and the impact of HIV/AIDS among A
Region's Premier Culinary Competition Turns Up the Heat for Philadelphia Magazine's 4th Annual PHILLY COOKS!(TM): For First Time, 50 Leading Chefs Put Oven Mitts on in Battle for 'DISH OF THE YEAR 2004' Benefiting MANNA; Presented in Partnership with NBC10: PRNewswire - December 11, 2003; PHILADELPHIA, Dec. 11 /PRNewswire/ -- The oven mitts are on.The chefs are prepping.And this year, the heat is being cranked up higher than ever, as for the first time, 50 of the Delaware Valley s leading epicurean talent prepare to do battle in what has become the area s premier culinary competition for DISH OF THE YEA
Clinical Trials Begin for Procleix(R) Ultrio(TM) Assay: Innovative Molecular Test Further Safeguards Blood Supply by Detecting Hepatitis B in Addition to HIV-1 and Hepatitis C: PRNewswire - December 11, 2003; EMERYVILLE, Calif. and SAN DIEGO, Dec. 11 /PRNewswire-FirstCall/ -- Chiron Corporation and Gen-Probe Incorporated announced today that clinical trials of the Procleix(R) Ultrio(TM) Assay, for the simultaneous detection of HIV-1, hepatitis C virus (HCV) and hepatitis B virus (HBV) in donated blood, plasma, organs and ti
Theratechnologies completes enrollment for Phase II trial in HIV-related lipodystrophy: PRNewswire - December 11, 2003; MONTREAL, Dec. 11 /PRNewswire-FirstCall/ - Theratechnologies announced today that it has completed enrolment for its Phase II clinical study in HIV-related lipodystrophy using ThGRF. HIV-related lipodystrophy is a metabolic syndrome that affects a large number of patients who are otherwise well controlled for HIV, and
Procleix(R) Testing Begins in England: 850,000 Units to Be Tested Annually With Chiron Nucleic Acid Test: PRNewswire - December 10, 2003; EMERYVILLE, Calif., Dec. 10 /PRNewswire-FirstCall/ -- Chiron Corporation today announced that the National Blood Service in England has begun nucleic acid testing (NAT) at its Brentwood site with the company s Procleix(R) HIV-1/HCV Assay. The assay is expected to test about one third of the 2.6 million units of blood a
AIDS Healthcare Foundation Says South African Competition Commission Settlement on GSK's AIDS Drug Pricing, 'Too Little, Too Late': PRNewswire - December 10, 2003; Settlement Follows Complaints Brought Against GSK by AHF and South African AIDS Activists. In October, the Commission Found GSK & Boehringer Ingelheim Guilty of Charging Excessively High Prices for Their Anti-AIDS Drugs. LOS ANGELES, Dec. 10 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), the US largest AIDS or
MTV and Kaiser Family Foundation Announce Extension of Emmy Award-Winning Public Education Campaign: Nearly 1 Million Young People Have Called Hotline for Information on Sexual Health: PRNewswire - December 10, 2003; New National Survey Shows Results Among Those Who Saw Campaign - Two-Thirds of Non-Sexually Active Youth Say it Made Them More Likely to Wait to Have Sex One-Quarter of Sexually-Active Youth Say They Got Tested for HIV or Other STDs As a Result NEW YORK, Dec. 10 /PRNewswire/ -- MTV: Music Television and the Kaiser Fami
GlaxoSmithKline Statement on the Publication of Studies Comparing Antiretroviral Treatment Options: (Statement from Douglas Manion, M.D., Vice President of Clinical Development for HIV Products, GSK): PRNewswire - December 10, 2003; RESEARCH TRIANGLE PARK, N.C., Dec. 10 /PRNewswire/ -- We welcome the publication in the Dec. 11 issue of New England Journal of Medicine of the results of ACTG384, a study comparing anti-HIV treatment regimens, conducted by the Adult AIDS Clinical Trials Group (ACTG), a clinical research program sponsored by the Nation
Targeted Genetics, IAVI, CCRI Begin Human Trial of Vaccine Candidate To Prevent HIV/AIDS: PRNewswire - December 9, 2003; SEATTLE and NEW YORK, Dec. 9 /PRNewswire-FirstCall/ -- Targeted Genetics Corp. (Nasdaq: TGEN), the nonprofit International AIDS Vaccine Initiative (IAVI) and Columbus Children s Research Institute (CCRI) have begun testing in humans a new vaccine candidate to prevent HIV/AIDS. A human clinical trial of vaccine candidat
Health Dept. Film Takes Realistic Look at African American Gays and HIV: 'Kevin's Room 2' to be Aired at 9 p.m. Sunday, December 14 on WCIU-TV: PRNewswire - December 9, 2003; CHICAGO, Dec. 9 /PRNewswire/ -- A groundbreaking new film is now available from the Chicago Department of Public Health (CDPH) to help address the spread of HIV among gay and bisexual African American men -- as well as their girlfriends who may be unaware of their outside activities. Kevin s Room 2: Trust is a pioneeri
Trial of New Investigational AIDS Vaccine Begins in New York and Rochester - Healthy Volunteers Sought for New AIDS Vaccine Research Effort -: PRNewswire - December 8, 2003; NEW YORK, Dec. 8 /PRNewswire/ -- The Aaron Diamond AIDS Research Center (ADARC), an affiliate of The Rockefeller University, and the International AIDS Vaccine Initiative (IAVI) announced today that they have begun a human trial of a new investigational vaccine to prevent HIV/AIDS. The trial is actively seeking healthy
GenoMed Announces Possible Universal Viral Antidote: Could Be First Line of Defense Against Viral Bioterrorism: PRNewswire - December 8, 2003; ST. LOUIS, Dec. 8 /PRNewswire/ -- GenoMed Inc. ( the Company or GenoMed ) (Pink Sheets: GMED) announced today a possible antidote against most viruses, including SARS, influenza, Hantavirus, respiratory syncytial virus (RSV), monkeypox, Ebola virus, West Nile virus, St. Louis encephalitis, Eastern Equine encephalitis v
GlaxoSmithKline Donates $1.6 Million to African AIDS Clinics: PRNewswire - December 5, 2003; LONDON and PHILADELPHIA, Dec. 5 /PRNewswire/ -- As part of its long-standing commitment to care and community support for HIV/AIDS patients and developing world health initiatives, GlaxoSmithKline today announced a $1.6 million grant over 2 years to support the work of two HIV/AIDS clinics in
Planned Parenthood Los Angeles With the City of Los Angeles and Clinica Monsenor Oscar Romero Join Forces to Raise Awareness of HIV/AIDS: PRNewswire - December 5, 2003; -- Leading Community Organizations to Host Event With Free HIV Testing, Information Booths and Theatrical Presentations on December 5 At Romona Hall in Los Angeles LOS ANGELES, Dec. 5 /PRNewswire/ -- Planned Parenthood Los Angeles (PPLA) Promotoras Comunitarias, one of L.A. County s leading Latino family outreach progr
National Organization of Concerned Black Men To Focus on HIV/AIDS at Annual Meeting: PRNewswire - December 4, 2003; WASHINGTON, Dec. 4 /PRNewswire/ -- The National Organization of Concerned Black Men s (CBM) approach to the HIV/AIDS epidemic is through education focused on the African-American youth. This year the delegates at the annual meeting, which will be held this weekend at the Washington Terrace Hotel in Washington, DC, on D
Bristol-Myers Squibb Commits to Funding New Pediatric HIV/AIDS Center in Africa: Promise of Better Future for HIV/AIDS Pediatric Care: PRNewswire - December 3, 2003; NEW YORK, Dec. 3 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb (BMY) Chairman and Chief Executive Officer Peter R. Dolan today committed to fund a second center to care for children with HIV/AIDS in Africa. He joined Health and Human Services Secretary Tommy G. Thompson and a number of organizations in increasing comm
Lipid Sciences Launches Non-Human Primate Studies in Validation of Viral Immunotherapy Platform: Development of Therapeutic Vaccine Approach for Use Against HIV: PRNewswire - December 3, 2003; PLEASANTON, Calif., Dec. 3 /PRNewswire-FirstCall/ -- Lipid Sciences, Inc. (Nasdaq: LIPD) announced today that with the recent completion of successful studies in a mouse animal model, it has achieved an important development milestone. Therefore, the Company has now initiated a series of non-human primate studies to fu
Calypte Biomedical and Earvin 'Magic' Johnson Commemorate World AIDS Day December 1st: PRNewswire - December 2, 2003; ALAMEDA, Calif., Dec. 2 /PRNewswire-FirstCall/ -- Calypte Biomedical Corporation (OTC Bulletin Board: CYPT), the developer and marketer of the only two FDA approved HIV-1 antibody tests for use with urine samples, today announced that Calypte s Chairman Tony Cataldo and Magic Ervin Johnson spent December 1st, World AID
Genetronics and Chiron Extend Collaborative Agreement on Technology for HIV Vaccine Delivery: PRNewswire - December 2, 2003; SAN DIEGO, Dec. 2 /PRNewswire-FirstCall/ -- Genetronics Biomedical Corporation (Amex: GEB) announced today that it has extended a collaborative agreement with Chiron Corporation, Emeryville, CA to conduct additional experiments using Electroporation, Genetronics proprietary technology, to test an HIV DNA vaccine. Finan
Medical Services President Invited to Meet With Senior Chinese Health Officials: PRNewswire - December 2, 2003; EDMONTON, Alberta, Dec. 2 /PRNewswire-FirstCall/ -- Medical Services International Inc. (Pinksheets: MSITF) is pleased to announce that the Company President, Robert Talbot has been invited to meet with Senior Health Officials in the People s Republic of China . Final preparations are currently underway for the meeting
Bavarian Nordic Invests USD 40 Million in Production Facility: PRNewswire - December 2, 2003; COPENHAGEN, Denmark , Dec. 2 /PRNewswire/ -- Bavarian Nordic acquires a pharmaceutical production facility and establishes its own production of vaccines. The facility will be one of Europe s largest production sites for vaccines with the capacity to produce up to 120 million doses per year.
Locus Pharmaceuticals and IBM Collaborate to Find Cure for AIDS; IBM Supercomputing Power to Accelerate Drug Discovery: PRNewswire - December 2, 2003; BLUE BELL, Pa., Dec. 2 /PRNewswire/ -- Locus Pharmaceuticals, a leading company in computational-based small molecule drug design and development, announced today a strategic collaboration with IBM s Deep Computing Capacity on Demand center to deploy supercomputing power for research and drug design. This effort, while
Pager-Size Medication Reminder Helps Patients Take Medication Correctly; Helps Healthcare Providers Manage Medication Compliance: PRNewswire - December 2, 2003; ROCKVILLE, Md., Dec. 2 /PRNewswire/ -- Vivonex, LLC, a corporation headquartered in Rockville, MD and Key Largo, FL, announces the availability of NexDose(R), a medication reminder to assist people of all ages who take medication. NexDose(R) helps patients take medications correctly by sounding an alarm when a dose of
Government of Romania, Ministry of Health: Romania Releases New Video Chronicling Progress Against HIV/AIDS: PRNewswire - December 1, 2003; -- A Reason for Joy: Success against HIV/AIDS in Romania Features Commentary From President Ion Iliescu, Dr. Peter Piot, Fmr. Sec. of State Madeleine Albright BUCHAREST, Romania, Dec. 1 /PRNewswire/ -- On the Romanian National Day of Celebration and World AIDS Day, the Government of Romania today announced the release
World AIDS Day, 2003: A Proclamation by the President of the United States of America: PRNewswire - December 1, 2003; WASHINGTON, Dec. 1 /PRNewswire/ -- The following is a proclamation by President Bush: The HIV/AIDS pandemic presents one of the greatest medical and social challenges of our time. On World AIDS Day, members of the global community come together to demonstrate our shared commitment to turning the tide against the spread
New Website Launched for World AIDS Day; AIDSribbons.com Debuts Today: PRNewswire - December 1, 2003; HUNTINGTON, N.Y., Dec. 1 /PRNewswire/ -- To mark World AIDS Day, the Long Island Network of Community Services (LINCS) has launched AIDSribbons.com (http://www.AIDSribbons.com), an important new presence on the worldwide web. According to UNAIDS statistics, there were 38.6 million adults and 3.2 million children living
Pharmaprojects Highlights Urgent Need to Intensify AIDS Drug and Vaccine Development: PRNewswire - December 1, 2003; RICHMOND, England, Dec. 1 /PRNewswire/ -- On World AIDS Day 2003, the leading pharmaceutical R&D database Pharmaprojects reviews the current status of AIDS drug development, and highlights the urgent need to expedite the introduction of new and effective medicines. Data released last week by UNAIDS show a
AHF Praises World Health Organization's Ambitious '3 x 5' Plan: WHO Plan to Provide ARVs to 3 Million People Worldwide by 2005 Seen as 'Lifeline for Millions': PRNewswire - December 1, 2003; LOS ANGELES, Dec. 1 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), the US largest AIDS organization which operates free HIV treatment clinics in the US, South Africa , Uganda , and Honduras , today praised the World Health Organization s (WHO) announcemen
AIDS Healthcare Foundation to Host World AIDS Day 'Save a Life' Fundraiser At West Hollywood's 'here' Nightclub: 'Buffy the Vampire Slayer' Props to Benefit Global AIDS Patients At World AIDS Day Fundraiser: PRNewswire - November 26, 2003; -- Donated Props & Set Pieces From Cult TV Show to be Sold at Gala -- Proceeds Benefit AIDS Healthcare Foundation, the Nation s Largest Specialized Provider of HIV/AIDS Medical Care and Will Help Support AHF s Free AIDS Clinics in South Africa , Uganda &
Update: Bristol-Myers Squibb Company Announces $30 Million In New Secure The Future (R) Grants For African Hiv/Aids Crisis: PRNewswire - November 25, 2003; -- Largest Corporate Commitment of its Kind Poised to More Effectively Fight Pandemic in World s Hardest-Hit Region NEW YORK, Nov. 25 /PRNewswire/ -- On the eve of World AIDS Day, Bristol- Myers Squibb Company (NYSE: BMY) announced today the next phase of SECURE THE FUTURE(R) with the allocation of six new program gran
BET Plans Special World AIDS Day Programming: Network's Popular News and Music Programming to Promote Public Awareness; Documentary Special to Focus on HIV/AIDS Issues Facing African-American Women: PRNewswire - November 25, 2003; WASHINGTON, Nov. 25 /PRNewswire/ -- BET today announced its plans to provide special programming to coincide with World AIDS Day, which will be commemorated globally on Monday, December 1. The cable network will televise HIV-related programs and public service announcements (PSAs) throughout the day that are geared to
Nelson Mandela Foundation Selects AT&T Toll-Free Services To Support '46664' AIDS Awareness Campaign: PRNewswire - November 25, 2003; -- By dialing 1-866-614-6664 callers in the U.S. and Canada can register their concern and donate to AIDS charity BEDMINSTER, N.J., Nov. 25 /PRNewswire/ -- AT&T today announced that it has been selected by the Nelson Mandela Foundation to provide toll-free telephone service in the Unite
IAVI Statement On Latest HIV/AIDS Statistics: Cycle of New Infections Must Be Broken: PRNewswire - November 25, 2003; NEW YORK, Nov. 25 /PRNewswire/ -- Five million adults and children worldwide became infected in 2003 with HIV, the virus that causes AIDS, according to statistics released by UNAIDS in advance of World AIDS Day. The epidemic continues its path of devastation; the latest statistics on infection rates mirror those from p
World AIDS Day 2003 - Young People Speak Out: Special preview screening of Nickelodeon's and The N's specials on young people and HIV/AIDS: PRNewswire - November 25, 2003; NEW YORK, Nov. 25 /PRNewswire/ -- On Monday, 1 December, UNICEF, in partnership with the Kaiser Family Foundation, Nickelodeon and the teen network, The N, will screen excerpts from two new specials on youth and HIV/AIDS, Nick News: The Courage to Live: Kids, South Africa and AIDS, and A Walk In Your Shoes: Living With
Showtime Commemorates World AIDS Day On December 1: Six Original Short Films To Be Hosted By Alec Baldwin & Airing Of 'Longtime Companion': PRNewswire - November 25, 2003; NEW YORK, Nov. 25 /PRNewswire/ -- In observance of World AIDS Day on December 1, SHOWTIME presents programming featuring AIDS-related topics. Beginning at 10:00 PM (ET/PT), the network will air a series of six short films from young filmmakers from the Kanbar Institute of Film and Television at NYU s Tisch School of th
GlaxoSmithKline Launches HepatitisBHelp.com : New Web site a Hepatitis B Resource for Healthcare Professionals and the Public: PRNewswire - November 25, 2003; RESEARCH TRIANGLE PARK, N.C., Nov. 25 /PRNewswire/ -- GlaxoSmithKline (GSK) today announced the launch of HepatitisBHelp.com (URL: http://www.hepatitisbhelp.com ), a new Web site that will serve as an important resource for US-based healthcare professionals and patients living with chronic hepatitis B. The site will a
83 New Medicines in Development for HIV/AIDS: PRNewswire - November 24, 2003; WASHINGTON, Nov. 24 /PRNewswire/ -- The pharmaceutical research industry is continuing its effort to develop more effective ways to prevent and treat HIV/AIDS, with 83 new medicines in development, a new survey by the Pharmaceutical Research and Manufacturers of America (PhRMA) shows. In addition to the 80 medicines al
KNOW HIV/AIDS Campaign to Support World AIDS Day: PRNewswire - November 24, 2003; -- Viacom and Kaiser Family Foundation s multi-platform initiative delivers HIV/AIDS awareness and prevention messages through events, cable television programming and public service announcements NEW YORK, Nov. 24 /PRNewswire/ -- KNOW HIV/AIDS, the ground-breaking cross-platform media campaign launched in January 2003
UNICEF Appoints Sesame Street Muppet Kami As a Global 'Champion for Children': PRNewswire - November 24, 2003; NEW YORK and GENEVA, Nov. 24 /PRNewswire/ -- UNICEF today formally appointed Kami, the HIV-positive Muppet who appears regularly on the South African co-production of Sesame Street called Takalani Sesame, as a global Champion for Children . Kami s first appearance with UNICEF under this new collaboration will be in Gen
Celebrities to Come Out Around the Globe In Support of MAC AIDS Fund and VIVA GLAM on World AIDS Day: PRNewswire - November 24, 2003; -- Bebe Neuwirth, Peggy Fleming, Miss USA, Rita Rudner, David Hasselhoff, Cassandra Wilson, Jully Black, Canadian Olympic Athlete Donna Clark, Stars From American Dreams, Guiding Light, Days of Our Lives To Make Appearances Dec. 1 To Help Reach $1 Million Goal NEW YORK, Nov. 24 /PRNewswire/ -- On World AIDS Day, Monday
Bristol-Myers Squibb Company Announces $30 Million in New SECURE THE FUTURE (R) Grants for African HIV/AIDS Crisis: PRNewswire - November 24, 2003; -- Largest Corporate Commitment of its Kind Poised to More Effectively Fight Pandemic in World s Hardest-Hit Region NEW YORK, Nov. 24 /PRNewswire/ -- On the eve of World AIDS Day, Bristol- Myers Squibb Company (NYSE: BMY) announced today the next phase of SECURE THE FUTURE(R) with the allocation of six new program gran
Pep Provides The Pulse For World AIDS Day Gifts: PRNewswire - November 20, 2003; CAPE TOWN, South Africa , November 20 /PRNewswire/ -- South Africa s biggest retailer, Pep has mounted a massive distribution initiative in a bid to deliver over 100 000 desperately needed items of clothing, footwear and toys to AIDS charities and orphanages nationally. With 870 stores, Pep is using its formidable stor
New Pfizer Foundation Partnerships Take Action to Combat Alarming Rise of HIV/AIDS in the South: PRNewswire - November 20, 2003; NEW YORK, Nov. 20 /PRNewswire/ -- Dramatic increases in the number of new HIV/AIDS infections in the South -- especially among women, African Americans and Latinos -- prompted the Pfizer Foundation to invest in prevention programs as the best defense against further spread of the disease in the region with a series of
Georgia HIV/AIDS Prevention Programs Partner in New Pfizer Foundation Initiative Aimed at Combating the Epidemic in the Southern States: Four Georgia Organizations Awarded Grants: PRNewswire - November 20, 2003; NEW YORK, Nov. 20 /PRNewswire/ -- The Pfizer Foundation today announced new partnership grants with Georgia HIV/AIDS organizations. The grants are the central element in a major new initiative in nine southern states to combat the alarming rise in AIDS cases in the region. Four Georgia HIV/AIDS organizations receiv
Louisiana HIV/AIDS Prevention Programs Partner in New Pfizer Foundation Initiative Aimed at Combating the Epidemic in the Southern States: Three Louisiana Organizations Awarded Grants: PRNewswire - November 20, 2003; NEW YORK, Nov. 20 /PRNewswire/ -- The Pfizer Foundation today announced new partnership grants with Louisiana HIV/AIDS organizations. The grants are the central element in a major new initiative in nine southern states to combat the alarming rise in AIDS cases in the region. Three Louisiana HIV/AIDS organizations r
Mississippi HIV/AIDS Prevention Programs Partner in New Pfizer Foundation Initiative Aimed at Combating the Epidemic in the Southern States: Two Mississippi Awarded Grants: PRNewswire - November 20, 2003; NEW YORK, Nov. 20 /PRNewswire/ -- The Pfizer Foundation today announced new partnership grants with Mississippi HIV/AIDS organizations. The grants are the central element in a major new initiative in nine southern states to combat the alarming rise in AIDS cases in the region. Two Mississippi HIV/AIDS organizations
Texas HIV/AIDS Prevention Programs Partner in New Pfizer Foundation Initiative Aimed at Combating the Epidemic in the Southern States: Three Organizations in Texas Awarded Grants: PRNewswire - November 20, 2003; NEW YORK, Nov. 20 /PRNewswire/ -- The Pfizer Foundation today announced a new partnership grant with Texas HIV/AIDS organizations. These grants are a central element in a major new initiative in nine southern states to combat the alarming rise in AIDS cases in the region. Three Texas HIV/AIDS organizations received
GlaxoSmithKline Drug Discovery and Development Research Grant Program 2003: $500,000 in Research Grants Awarded to Five Researchers Working Toward Breakthroughs in HIV/AIDS Drug Therapies: PRNewswire - November 20, 2003; RESEARCH TRIANGLE PARK, N.C., Nov. 20 /PRNewswire/ -- Five researchers have been awarded 2003 GlaxoSmithKline (GSK) Drug Discovery and Development Research Grants for their efforts to develop new pharmaceutical strategies to combat HIV, the virus that causes AIDS. The recipients, who will share $500,000 in grant money,
South Carolina HIV/AIDS Prevention Programs Partner in New Pfizer Foundation Initiative Aimed at Combating the Epidemic in the Southern States: Two South Carolina Organizations Awarded Grants: PRNewswire - November 20, 2003; NEW YORK, Nov. 20 /PRNewswire/ -- The Pfizer Foundation today announced new partnership grants with South Carolina HIV/AIDS organizations. The grants are the central element in a major new initiative in nine southern states to combat the alarming rise in AIDS cases in the region. Two South Carolina HIV/AIDS organiz
North Carolina HIV/AIDS Prevention Programs Partner in New Pfizer Foundation Partnership Aimed at Combating The Epidemic in the Southern States: Three North Carolina Organizations Awarded Grants: PRNewswire - November 20, 2003; NEW YORK, Nov. 20 /PRNewswire/ -- The Pfizer Foundation today announced new partnership grants with North Carolina HIV/AIDS organizations. The grants are the central element in a major new initiative in nine southern states to combat the alarming rise in AIDS cases in the region. Three North Carolina HIV/AIDS organ
Alabama HIV/AIDS Prevention Programs Partner in New Pfizer Foundation Initiative Aimed at Combating the Epidemic in the Southern States: Two Alabama Organizations Awarded Grants: PRNewswire - November 20, 2003; NEW YORK, Nov. 20 /PRNewswire/ -- The Pfizer Foundation today announced new partnership grants with Alabama HIV/AIDS organizations. The grants are the central element in a major new initiative in nine southern states to combat the alarming rise in AIDS cases in the region. Two Alabama HIV/AIDS organizations receive
Florida HIV/AIDS Prevention Programs Partner in New Pfizer Foundation Initiative Aimed at Combating the Epidemic in the Southern States: Four Florida Organizations Awarded Grants: PRNewswire - November 20, 2003; NEW YORK, Nov. 20 /PRNewswire/ -- The Pfizer Foundation today announced new partnership grants with Florida HIV/AIDS organizations. The grants are the central element in a major new initiative in nine southern states to combat the alarming rise in AIDS cases in the region. Four Florida HIV/AIDS organizations receiv
Tennessee HIV/AIDS Prevention Program Partners in New Pfizer Foundation Initiative Aimed at Combating the Epidemic in The Southern States: PRNewswire - November 20, 2003; NEW YORK, Nov. 20 /PRNewswire/ -- The Pfizer Foundation today announced a new partnership grant with a Tennessee HIV/AIDS organization. The grant is part of the central element in a major new initiative in nine southern states to combat the alarming rise in AIDS cases in the region. A Tennessee HIV/AIDS organizatio
In Rousing Speech, Ugandan Health Minister Dedicates New Free AIDS Treatment Center in Soroti, Uganda, Vows to Work, 'Side by Side, Soul to Soul,' With AIDS Healthcare Foundation in AIDS Fight: PRNewswire - November 20, 2003; -- The Honorable Captain George Michael Mukula Dedicates Uganda Cares Soroti Healthcare Center in Official Ceremony as Part of Country s Rapid Scale Up Efforts for ARV Access. -- New Clinic is Second, After Masaka District Clinic, in Uganda Cares Partnership Between the Ministry of Health/Government of Uganda, and AIDS
Medical Services Starts Additional Testing of its HIV Test Kit in the United States: PRNewswire - November 20, 2003; EDMONTON, Alberta, Nov. 20 /PRNewswire-FirstCall/ -- Medical Services (Pinksheets: MSITF) is pleased to announce that the final set of testing of its VScan HIV 1&2 rapid test Kit has started and that the preliminary results meet the Company s expectations. It was previously announced that the first set of live test
ADVR's AVR118 Granted a Patent in China for the Treatment of AIDS: Large Potential Market as HIV Infection Continues Alarming Spread: PRNewswire - November 20, 2003; YONKERS, N.Y., Nov. 20 /PRNewswire-FirstCall/ -- Advanced Viral Research Corp. (OTC Bulletin Board: ADVR) today announced that China has recently granted the Company a patent for the treatment of AIDS patients with AVR118 (formerly known as Product R). The claims in the patent awarded by China cover the administration
Market for Peripheral Neuropathy Among Diabetics, HIV/AIDS and Cancer Patients Approaches $1B by 2012: PRNewswire - November 20, 2003; SAN FRANCISCO, Nov. 20 /PRNewswire/ -- Prevention and reversal of damage to peripheral nerves -- peripheral neuropathy -- continues to confound clinicians and their patients worldwide. More than one million people in the U.S., Europe, and Japan suffer the symptoms of this frequently under-diagnosed and irreversi
Medical Services HIV Test Kit Excels in Live Testing: PRNewswire - November 19, 2003; EDMONTON, Alberta, Nov. 19 /PRNewswire-FirstCall/ -- On October 30, 2003, Medical Services International Inc. (Pinksheets: MSITF) announced that it had agreed to begin live testing in medical clinics in Florida. On November 7, 2003 the Company announced that it had received approval to begin live testing from the Indep
AIDS Healthcare Foundation: CalPERS to Reopen GSK's AIDS Drug Pricing Issue: PRNewswire - November 19, 2003; -- CalPERS Board Responds to Plea From AIDS Healthcare Foundation Advocates to Press GSK on Letter From CalPERS, Votes 10 to 1 to Put Issue Back on Agenda LOS ANGELES, Nov. 19 /PRNewswire/ -- The mammoth California Public Employees Retirement System (CalPERS) -- which is estimated to hold $850 million in
Two Documentum Customers, Boehringer Ingleheim Pharmaceuticals, Inc. and The Well Project, Win InfoWorld 100 Awards: Customer IT Projects Honored For Innovative Use of Documentum Collaboration and Enterprise Content Management Solutions: PRNewswire - November 19, 2003; PLEASANTON, Calif., Nov. 19 /PRNewswire-FirstCall/ -- Documentum (Nasdaq: DCTM), the leading provider of enterprise content management (ECM), today announced that two of its customers, Boehringer Ingleheim Pharmaceuticals, Inc. and The Well Project, have been named to the InfoWorld 100 for outstanding Documentum-based
Ortho Biotech Announces Partnership With AIDS Alliance on HIV Strength for Caring Program: Unique National Initiative Offers Support and Education for Caregivers of People Living with HIV/AIDS: PRNewswire - November 18, 2003; BRIDGEWATER, N.J., Nov. 18 /PRNewswire/ -- Ortho Biotech Products, L.P. today announced a partnership with AIDS Alliance for Children, Youth and Families to further strengthen the HIV Strength for Caring program-a comprehensive support program and resource for HIV caregivers. The announcement coincides with National Fa
Ugandan President to Attend Dedication of New 'Uganda Cares' Free AIDS Treatment Center in Soroti, Uganda: PRNewswire - November 18, 2003; -- His Excellence, Yoweri Kaguta Museveni, to Dedicate Soroti Healthcare Center in Official Ceremony on Wednesday, November 19th as Part of Country s Rapid Scale Up Efforts for ARV Access -- New Clinic is Second, After Masaka District Clinic, in Partnership Between The Ministry of Health/ Government of
US' Largest AIDS Organization, Episcopal Churches, and Honduras Sign AIDS Clinic Agreement: AIDS Healthcare Foundation, Episcopal Church and Honduran Ministry of Health To Include Three Clinics in Hard-hit Central American Country and Its Caribbean Island of Roatan: PRNewswire - November 17, 2003; LOS ANGELES and TEGUCIGALPA, Honduras , Nov. 17 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), the US largest AIDS organization, today announced a partnership with the Honduran government and Episcopal Churches to operate at least three HIV clinics in Central America s hardest-hit country.
BBC World Service Trust Launches Educational HIV/AIDS Campaign on the World Service Airwaves: PRNewswire - November 17, 2003; -- Messages and Programs to Be Broadcast to Africa and the Caribbean, Through a BBC World Service Trust, Kaiser Family Foundation and Viacom Partnership LONDON and NEW YORK, Nov. 17 /PRNewswire/ -- BBC World Service Trust, the international charitable arm of the BBC, in partnership with the Kaiser Family Foundation, a
First-of-Its-Kind Forum Assesses the Future of Publicly-Funded U.S. HIV Care: PRNewswire - November 17, 2003; WASHINGTON, Nov. 17 /PRNewswire/ -- Federal and state officials, public health leaders, community advocates, and HIV/AIDS service providers gathered in Washington, DC on November 13-15, 2003 at the National Policy Forum on Future Funding for HIV Care to address the ongoing state and federal challenges related to caring
New Drug Approved for Treating HIV Children With Depression: PRNewswire - November 17, 2003; BUCHAREST, Romania , Nov. 17 /PRNewswire/ -- Cortisol Research International-Romania announced today that the National Medicines Agency of Romania has approved the use of its drug, VIRUCORT 50 in the treatment of depression of HIV-positive children. This drug represents a new approach in the fight against AIDS and pote
FDA Grants Fast Track Designation for 1.0% C31G Vaginal Gel for the Reduction of HIV Transmission: PRNewswire - November 17, 2003; HUNTINGDON VALLEY, Pa., Nov. 17 /PRNewswire/ -- Biosyn, Inc. announced today that the U.S. Food and Drug Administration ( FDA ) has granted Fast Track designation for the development program of 1.0% C31G vaginal gel for the reduction of HIV transmission. In granting the Fast Track designation, the FDA recognized that H
ViroLogic Announces New Jersey Medicaid Initiates Policy Covering HIV Drug Resistance Tests: 48 States and the District of Columbia Medicaid Programs Now Reimburse for Resistance Testing: PRNewswire - November 17, 2003; SOUTH SAN FRANCISCO, Calif., Nov. 17 /PRNewswire-FirstCall/ -- ViroLogic, Inc. (Nasdaq: VLGC) today announced that the New Jersey Medicaid Program has initiated a benefit coverage policy for phenotypic and genotypic HIV drug resistance testing, effective November 1, 2003. New Jersey joins 47 other states and the Distri
VH1 News Presents: 'AIDS: A Pop Culture History' Premiering in Recognition of World Aids Day, Monday, December 1 at 9:00 PM*: PRNewswire - November 17, 2003; -- Hosted By Ashley Judd, YouthAIDS Global Ambassador, One-Hour Documentary Examines the History of AIDS as Seen Through the Prism of Media and Culture -- Concert Special 46664 Airs Immediately Following at 10:00 PM, Featuring Beyonce, Bono, 50 Cent and More as Part of Nelson Mandela s Worldwide Music-Led Campaign for
MedMira makes rapid in-roads in Chinese market: PRNewswire - November 17, 2003; HALIFAX, Nov. 17 /PRNewswire-FirstCall/ - MedMira Inc. (MedMira) (TSX Venture: MIR) announced today that it has finalized arrangements with Long Hao Healthcare Technology Company Ltd., of Guangzhou, China , which will act as distributors for MedMira MiraWell(TM) Rapid HIV tests. MedMira also announced an increase in th
Davis Appointee Defies 11th-Hour Reversal of Multi-Million Dollar Aids Cut: PRNewswire - November 16, 2003; -- DHS Head Diana Bonta Refuses Davis Directive, Continues Her Short-Sighted Plan to Cut $7M From $8M Medical Testing Program - an 87% Cut - Which Davis Reversed Last Week -- AIDS Healthcare Foundation Had Spearheaded AIDS Community Support to Restore Funding, Urges Governor-Elect Schwarzenegger to Honor Davis Request
AIDS Healthcare Foundation Praises Gov. Davis for Restoring AIDS Funding to Crucial California Testing Program: PRNewswire - November 14, 2003; -- State Bureaucrats Plan to Cut $7M From $8M Medical Testing Program - an 87% Cut - Reversed by Davis: AHF Spearheaded AIDS Community Support to Restore Funding, Urges Governor-Elect Schwarzenegger to Honor Davis Action LOS ANGELES, Nov. 14 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), the nation s largest AIDS or
CYC202 Beneficial Effects In Kidney Disease Models Reported In Major Nephrology Conference: Preclinical Studies Underpin Rationale for Phase II Clinical Trials: PRNewswire - November 14, 2003; SAN DIEGO, Nov. 14 /PRNewswire/ -- Cyclacel Limited, the UK-based biopharmaceutical company, announced today encouraging results by independent American and German investigators testing its CYC202 experimental CDK inhibitor drug in models of two variants of glomerulonephritis: collapsing glomerulopathy (a disease in wh
Shell and Africare Form Partnership to Launch $4.5 Million Health Care Programme in Nigeria: PRNewswire - November 14, 2003; LONDON, Nov. 14 /PRNewswire/ -- The Shell Petroleum Development Company of Nigeria Limited (Shell) and Africare today announced the signing of a partnership agreement to establish a $4.5 million health care programme in Nigeria. Shell will contribute $3.4 million of the programme s costs over the next three years, with
QT 5 Supplies Ten-Minute HIV Test for Evaluation by Dept. of Defense: PRNewswire - November 14, 2003; WESTLAKE VILLAGE, Calif., Nov. 14 /PRNewswire-FirstCall/ -- QT 5, Inc. (OTC Bulletin Board: QTFV), manufacturer, distributor and marketers of biomedical diagnostics and NICOWater(TM), a Homeopathic Nicotinum Formula, today announced it has submitted their recently acquired ten-minute HIV1 and HIV2 qualitative diagnosti
New Documentary Offers Intimate Look Inside the HIV/AIDS Epidemic in Baltimore, Maryland: Personal Stories Illustrate Extent of Problem in Urban Baltimore: PRNewswire - November 13, 2003; BALTIMORE, Nov. 13 /PRNewswire/ -- Rickeena Free has never known life without HIV/AIDS. She was just a baby when her mother found out she unknowingly transmitted the HIV virus to her daughter. Now 15, Rickeena faces the typical challenges of any teenager while also coping with her HIV infection. This is just one of the
AIDS Groups Seek Damages Against GSK for Patients Harmed in Illegal Pricing Scheme in South Africa: PRNewswire - November 13, 2003; -- New Joint Action Suit by AIDS Healthcare Foundation Global Immunity & AIDS Therapeutic Treatment Now, South Africa , Reaches Out to Those Harmed by GSK s Actions & Their Inability to Get Life-saving AIDS Medications. Last Month, South African Commission Found Against GSK in Competition Complaint WHAT:
Primagen Holding B.V. to Partner With AIDS Healthcare Foundation Global Immunity to Provide Viral Load Test Kits & Technology for Free AIDS Clinic in Durban, South Africa: 'Ithembalabantu' AIDS Treatment Clinic in South Africa to Get Free Viral Load Testing Services: PRNewswire - November 11, 2003; LOS ANGELES and DURBAN, South Africa , Nov. 11 /PRNewswire/ -- In an effort to provide high quality, cost-effective HIV monitoring to support the continuing roll out of AIDS Healthcare Foundation Global Immunity s (AHF GI) anti-retroviral treatment program in South Africa, the US and South African operators of the Ithe
Holiday Gifts That Make a Difference for Those With HIV/AIDS: 100 Percent of Sales From Kids Helping Kids Holiday Cards, Viva Glam Lipstick and Lip Compact Go Directly to Men, Women and Children With HIV/AIDS: PRNewswire - November 11, 2003; NEW YORK, Nov. 11 /PRNewswire/ -- Not quite sure if you should buy a gift for someone or make a donation to charity this holiday season? MAC Cosmetics has solved that dilemma and offers the best of both worlds: three hip stocking stuffers with 100 percent of sales for each product going directly to the MAC AIDS Fund, t
Tanox, Inc. Announces Positive Preliminary Results in TNX-355 Phase 1b Trial: PRNewswire - November 11, 2003; HOUSTON, Nov. 11 /PRNewswire-FirstCall/ -- Tanox, Inc. (Nasdaq: TNOX) today announced continuing evidence of the tolerability and antiretroviral activity of TNX-355 from preliminary analysis of its multi-dose Phase 1b clinical trial in human immunodeficiency virus-1 (HIV-1)-infected patients. Twenty-two (22) patients r
Healthy Couples 101: A Lesson in Living With a Lifelong STD: Dr. Ruth Helps Those With Genital Herpes Lead a Healthy Love Life -: PRNewswire - November 11, 2003; NEW YORK, Nov. 11 /PRNewswire/ -- What happens when one partner in a relationship has a contagious and lifelong sexually transmitted disease (STD), like genital herpes ? Is this the end of intimacy, both emotionally and physically? It doesn t have to be, according to a panel of experts that gathered in New York today t
International Political and Security Risks: What Can We Expect in 2004? : Control Risks Group Publishes RiskMap to Forecast Opportunities and Trouble Spots for 2004: PRNewswire - November 11, 2003; WASHINGTON, Nov. 11 /PRNewswire/ -- Geopolitical uncertainty, instability in key emerging markets, and the continued threats to international business posed by terrorism and crime have made international business more challenging than ever, so found Control Risks Group in its 12th annual risk survey, RiskMap 2004. Risk
BET's Rap-It-Up Hosts its First Citywide Health Forum November 22 At Morgan State University: PRNewswire - November 10, 2003; WASHINGTON, Nov. 10 /PRNewswire/ -- Rap-It-Up, BET s award-winning national HIV/AIDS public awareness initiative, brings its first citywide health forum to Morgan State University s Murphy Fine Arts Center on Saturday, November 22 at 1:00 p.m. Partnering with Rap-It-Up for the community effort are the Baltimore City Co
Elements of Green Tea Prevent HIV From Binding to Human T Cells, From the Journal of Allergy and Clinical Immunology: PRNewswire - November 10, 2003; MILWAUKEE, Nov. 10 /PRNewswire/ -- The major component of green tea prevents the binding of HIV to human T cells, the first step in HIV infection, according to a study and an accompanying editorial published in the November 2003 Journal of Allergy and Clinical Immunology (JACI). The JACI is the peer- reviewed journal o
Pfizer Scientist Named Research Leader on the 'Scientific American 50' : Award Recognises Discovery and Exploratory Development of a CCR5 Antagonist for Treating HIV/AIDS: PRNewswire - November 10, 2003; SANDWICH, England, Nov. 10 /PRNewswire-FirstCall/ -- Dr Chris Hitchcock, a biologist at Pfizer s Sandwich laboratories in the UK, has been named by Scientific American magazine as one of the Scientific American 50 -- the noted magazine s annual list recognising outstanding acts of leadership in technology during the pa
State Legislators Form Consortium to Eliminate Racial/Ethnic Disparities in Health Care: PRNewswire - November 10, 2003; -- Resolution Presented at the 2003 National Black Caucus of State Legislators and National Hispanic Caucus of State Legislators Health Care Disparities Conference: Noted Medical Experts and Government Officials Address Legislators WASHINGTON, Nov. 10 /PRNewswire/ -- For the first time in their respective histories, le
Harvard Educator Says Promiscuous Teen Sex Fueling Youth AIDS Epidemic Globally: PRNewswire - November 7, 2003; -- Dr. John Chittick now finishing up his 5-year, solo Global AIDS Walk to train teens as Peer Educators in 65 countries on 6 continents. First Walk of its kind BOSTON, Nov. 7 /PRNewswire/ -- On the eve of World AIDS Day, December 1, Harvard-trained Dr. John Chittick of Boston has released a statement that the findings
AIDS Healthcare Foundation, California Medical Association & Others File Suit to Stop Illegal Funding Cuts to Medical Providers Treating California Medicaid Patients:: PRNewswire - November 7, 2003; -- California Hit With Lawsuit Following $115M in Illegal Medi-Cal Cuts to Indigent Care Providers -- Ad Hoc Group of Health Care Providers Files Lawsuit Against State to Stop Illegal Five Percent Across-the-Board Cuts to Providers. Cuts Will Wreak Havoc with State s Care System, Threaten Continuity of Care for AIDS an
Calypte Biomedical Submits Investigational Device Exemption Application for HIV-1 Rapid Blood Test: PRNewswire - November 6, 2003; ALAMEDA, Calif., Nov. 6 /PRNewswire-FirstCall/ -- Calypte Biomedical Corporation (OTC Bulletin Board: CYPT), the developer and marketer of the only two FDA approved HIV-1 antibody tests for use with urine samples, announced today that it is submitting an application with the U.S. Food and Drug Administration (FDA) for
Chiron Opens State-of-the-Art Blood Screening Lab in China: Nucleic Acid Test (NAT) Center Utilizing Procleix(R) Assays: PRNewswire - November 6, 2003; EMERYVILLE, Calif., Nov. 6 /PRNewswire-FirstCall/ -- Chiron Corporation (Nasdaq: CHIR) today announced the opening of a Chiron nucleic acid testing (NAT) lab in China as part of the celebration of the fiftieth anniversary of the Beijing Blood Center. The Chiron NAT Lab will be utilized initially as a clinical trial sit
Article in The Journal of the American Medical Association Validates HDL Therapy: Lipid Sciences' HDL Therapy Has Potential to Dramatically Lower Risk of Cardiovascular Disease: PRNewswire - November 6, 2003; PLEASANTON, Calif., Nov. 6 /PRNewswire-FirstCall/ -- Lipid Sciences, Inc. (Nasdaq: LIPD), today announced that an article published on November 5, 2003 in the Journal of the American Medical Association (JAMA), supports the premise on which its Vascular Lipid Removal (VLR(TM))platform is based -- that stimulation of re
BD Applauds Senate Action to Prevent Unsafe Medical Practices That Can Cause HIV/AIDS Spread in Africa: PRNewswire - November 5, 2003; FRANKLIN LAKES, N.J., Nov. 5 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) applauded the U.S. Senate for providing funding to combat unsafe medical practices in Africa as a means of preventing the spread of HIV/AIDS on the continent. BD commends and supports the efforts of Senators Sessions,
Health Network Laboratories, a Pennsylvania Limited Partnership, Announces Agreement to Build Relationship with Roche Diagnostics: PRNewswire - November 5, 2003; ALLENTOWN, Pa., Nov. 5 /PRNewswire/ -- Health Network Laboratories (HNL), a leading regional provider of medical diagnostics in Pennsylvania and New Jersey, announced today a five-year strategic alliance agreement with the world s leading diagnostics company, Roche Diagnostics. Together the two will develop a Molecular
Judgment Entered Against Hospital Corporation for Needlestick: PRNewswire - November 5, 2003; CHEYENNE, Wyo., Nov. 5 /PRNewswire/ -- The United States District Court in Cheyenne has entered judgment for fifty thousand dollars to a woman stuck by a used needle while visiting a patient at one of Banner Health System s hospitals in Wyoming. A hospital employee had left the needle lodged in a heat register. The
Transgene Signs Pre-Clinical AIDS Vaccine Manufacturing Agreement With ANRS and INSERM: PRNewswire - November 3, 2003; STRASBOURG, France , Nov. 3 /PRNewswire-FirstCall/ -- Transgene (Nasdaq: TRGNY; Nouveau Marche: FR0005175080) announced today that it has entered into an agreement with the French AIDS Research Agency (Agence Nationale de Recherches sur le SIDA /ANRS) and the French Institute for Health and Medical Research (Institut N
The Immune Response Corporation Initiates a Preclinical Development Program with IR103, a New Vaccine Candidate for the Prevention and Treatment of HIV: PRNewswire - November 3, 2003; CARLSBAD, Calif., Nov. 3 /PRNewswire-FirstCall/ -- The Immune Response Corporation (Nasdaq: IMNR) announced today that it has initiated a preclinical development program with IR103, a new vaccine candidate for the prevention and treatment of HIV, the virus that causes AIDS. The program is based on the promising results
Documentum Links Physicians, Organizations and Activists in the Fight Against HIV/AIDS in Africa: Groups Use Documentum eRoom to Collaborate on the Construction of Clinic For the Treatment and Prevention of HIV/AIDS: PRNewswire - November 3, 2003; PLEASANTON, Calif., Nov. 3 /PRNewswire-FirstCall/ -- Documentum (Nasdaq: DCTM), the leading provider of enterprise content management (ECM), today announced that the Academic Alliance for AIDS Care & Prevention in Africa (AAACP or The Alliance) has implemented Documentum eRoom to collaborate on the building of a cl
IAVI Hails Start of AIDS Vaccine Testing in South Africa: PRNewswire - November 3, 2003; NEW YORK, Nov. 3 /PRNewswire/ -- The nonprofit International AIDS Vaccine Initiative (IAVI) today hailed the start of the first of several human trials to be conducted in South Africa to test vaccines to prevent HIV/AIDS. This marks one of the great moments in the global effort to stop the spread of the HIV/AIDS epidem
Sean 'P. Diddy' Combs Raises More Than $250,000 During Radio Telethon to Benefit Children's Charities: PRNewswire - October 31, 2003; -- Advent Capital Management, Breathe Right, David Barton Gym, Newmark Realty, Pepsi, Power 105, Time Warner, Viacom, WKTU, Xbox and Z100 Join List of Corporate Partners To Help Combs Efforts NEW YORK, Oct. 31 /PRNewswire/ -- Musician, fashion designer and entrepreneur Sean P. Diddy Combs spent more than 16 hours on th
AIDS Healthcare Foundation Praises Global AIDS Funding Increase: Senate Approves DeWine's $289 Million Amendment: PRNewswire - October 31, 2003; LOS ANGELES, Oct. 31 /PRNewswire/ -- AIDS Healthcare Foundation, the nation s largest AIDS organization released the following comment in response to the senate approval to the $289 million amendment to President Bush s Global AIDS initiative. Comment from AHF President Michael Weinstein: Additional funding is enough t
AIDSribbons.com to Debut Today: PRNewswire - October 30, 2003; HUNTINGTON, N.Y., Oct. 30 /PRNewswire/ -- Today, the Long Island Network of Community Services (LINCS) is launching AIDSribbons.com, an important new presence on the worldwide web. According to UNAIDS statistics, there were 38.6 million adults and 3.2 million children living with HIV at the end of 2002, and during the
Medical Services to Begin Live Testing of Its HIV Test Kit in Florida: PRNewswire - October 30, 2003; EDMONTON, Alberta, Oct. 30 /PRNewswire-FirstCall/ -- Medical Services International Inc. (Pinksheets: MSITF) is pleased to announce that the Company has agreed to begin live testing of its VScan HIV 1&2 rapid test kit in Florida. The live testing component will be important in the approval process being undertaken
80-Week Phase II Data of Tipranavir-Based Antiretroviral Therapy Presented at 9th European AIDS Conference: PRNewswire - October 30, 2003; WARSAW, Poland , Oct. 30 /PRNewswire/ -- New data from a Phase II study show that tipranavir-based therapy achieved viral suppression over 80 weeks in patients who have failed two or more protease inhibitor (PI)-containing regimens. These findings, along with 24-week Phase IIb efficacy data, were presented this week at
Senator Nickles Blocking AIDS Funding Increase: PRNewswire - October 29, 2003; WASHINGTON, Oct. 29 /PRNewswire/ -- Over sixty Senators were ready to vote last night on an amendment to increase funding for desperately needed global AIDS programs. But, standing in the way of the Republican-backed measure was Senator Don Nickles (R-OK). His threat of a filibuster blocked action and today still threa
Study Demonstrates Cardiovascular Disease is a Leading Cause for Hospital Admission Among HIV/AIDS Patients: PRNewswire - October 29, 2003; -- Study Presented at 9th European AIDS Conference (EACS) in Warsaw - WARSAW, Poland , Oct. 29 /PRNewswire/ -- Results from a recent study showed that cardiovascular disease is a leading cause for hospital admissions among HIV/AIDS patients(1). In an analysis of a large managed care database, researchers found that, c
Senate Could Reject Bush Stinginess on AIDS Spending: PRNewswire - October 28, 2003; Defying clear instructions from the White House, the US Senate today prepared to approve significant increases to AIDS, TB and malaria spending, to more than $300 million above the President s request. On October 16, the White House sent a letter to the Senate stating that, [T]he Administration strongly opposes any eff
Increases in Concentrations of 'Good' Cholesterol (HDL) Observed in Treatment-Naive HIV+ Patients in Phase III Study of New Protease Inhibitor Lexiva(TM): PRNewswire - October 28, 2003; -- Increases in the concentration of HDL-C were observed at 48 weeks in a clinical trial of the new PI Lexiva boosted with ritonavir . -- Lexiva was well-tolerated in clinical trials. The most common adverse events were diarrhea, nausea, vomiting, headache and rash. WARSAW,
Study Finds Viramune(R) Can Be Substituted for HIV/AIDS Patients Intolerant of Sustiva(R) Side Effects: PRNewswire - October 28, 2003; WARSAW, Poland , Oct. 28 /PRNewswire/ -- A new study presented this week by the Dupont Circle Physicians Group suggests that the HIV/AIDS drug, Viramune ( nevirapine ), can be successfully substituted for
Body Positive Names Eric Rodriguez Executive Director: PRNewswire - October 28, 2003; NEW YORK, Oct. 28 /PRNewswire/ -- Body Positive announced today the appointment of Eric Rodriguez to Executive Director. In his new role, Mr. Rodriguez is responsible for the day-to-day management of the organization including supervising the full time staff, coordination and evaluation of the outreach and education pr
Case Researchers Discover the Mouth's Defenses Against AIDS; New Findings Hold Potential for New Aids Prevention: PRNewswire - October 28, 2003; CLEVELAND, Oct. 28 /PRNewswire/ -- Researchers at Case Western Reserve University and the Cleveland Clinic have discovered a way that the mouth may prevent the contraction of HIV. The findings are reported in the new issue of the international journal AIDS. The researchers also added that the findings hold potential fo
New Study Shows Continuous Use of GlaxoSmithKline's Epivir-HBV Significantly Delayed Liver Complications Due to Chronic Hepatitis B: PRNewswire - October 28, 2003; -- Research Presented at AASLD Finds Long-Term Lamivudine Treatment Slows Disease Progression BOSTON, Oct. 28 /PRNewswire/ -- GlaxoSmithKline today announced the results of a new study that showed long-term treatment with Epivir-HBV(R) (lamivudine) delayed clinical progression in chronic hepatitis B patients with adva
Medical Services Completes Successful Testing In Belize: PRNewswire - October 28, 2003; EDMONTON, Alberta, Oct. 28 /PRNewswire-FirstCall/ -- Medical Services (Pinksheets: MSITF) is pleased to announce that it has completed all the necessary testing required for the country of Belize and now has the ability to ship the VScan test kits to Belize. These results were obtained through independent testing in a
Clients of Martha's Vineyard Holistic Retreat Achieving Dramatic Improvements and Recoveries from HIV, Hepatitis, Cancer, Obesity and other Chronic Illnesses: PRNewswire - October 28, 2003; -- Full-service year-round total wellness facility promotes wellness as a lifestyle! BOSTON, Oct. 28 /PRNewswire/ -- If you are dealing with chronic health and fitness issues, have consulted countless healthcare professionals, and don t know where else to turn, Martha s Vineyard Holistic Retreat (MVHR), a year- round h
Idenix Pharmaceuticals, Inc. Presents Positive 1-Year Data On Telbivudine (LdT) for the Treatment of Chronic Hepatitis B: Undetectable Virus Levels and Improved Liver Function Achieved In Majority of Patients on LdT: PRNewswire - October 28, 2003; BOSTON, Oct. 28 /PRNewswire/ -- Idenix Pharmaceuticals, Inc. today presented final 52-week results from an international phase IIb clinical trial of its lead drug candidate, telbivudine (LdT), at the 54th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in Boston, Massachusetts. This t
Human Genome Sciences Reports Interim Results of Phase 1/2 Clinical Trial of Albuferon(TM) in Patients Infected With Hepatitis C Virus: PRNewswire - October 28, 2003; -- Data Presented at the 54th Annual Meeting of the American Association for the Study of Liver Diseases Demonstrate Safety, Prolonged Half-Life, and Biological Activity ROCKVILLE, Md., Oct. 28 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) announced today that interim results from an ongoing clin
New Data Confirm Durable Benefit of FUZEON-Based Regimens Among Treatment-Experienced HIV Patients, Including Those With Less Advanced and Late Stage Disease: PRNewswire - October 27, 2003; WARSAW, Poland , Oct. 27 /PRNewswire-FirstCall/ -- When used in combination with other anti-HIV drugs, FUZEON(R) ( enfuvirtide ) provides a substantial virologic and immunologic benefit through 48 weeks in treatment-experienced patients living with less advanced HIV disea
Results From Study With Kaletra(R)-Based Regimen Showed No Evidence of PI Resistance in HIV Treatment-Naive Patients Through Five Years: PRNewswire - October 27, 2003; WARSAW, Poland , Oct. 27 /PRNewswire-FirstCall/ -- Data presented today at the 9th European AIDS Conference (EACS) showed no patient taking Abbott Laboratories protease inhibitor (PI) Kaletra (R) ( lopinavir /
Most HIV Patients Taking New Injectable Fusion Inhibitor For One Year Satisfied with Ease of Injection: PRNewswire - October 27, 2003; -- Research Conducted by Leading Clinician at Community Research Initiative of New England WARSAW, Poland , Oct. 27 /PRNewswire-FirstCall/ -- Most patients using the only injectable anti-HIV drug, enfuvirtide (Fuzeon(TM)), for one year saw little impact on their daily activities and found the injection process easier o
New Study Investigates Pegasys(R) and Copegus(R) for the Treatment of Chronic Hepatitis C in African Americans: PRNewswire - October 27, 2003; -- Important news for African Americans - Historically one of the most difficult to treat hepatitis C patient populations BOSTON, Oct. 27 /PRNewswire/ -- New data on response to treatment in African Americans with chronic hepatitis C using the combination of Pegasys(R) (peginterferon alfa-2a) and Copegus(R) (ribavirin,
Medical Services Completes Initial Testing in Peru: PRNewswire - October 27, 2003; EDMONTON, ALBERTA, Oct. 27 /PRNewswire-FirstCall/ -- On September 16, Medical Services International Inc (Pinksheets: MSITF) announced that it had begun shipping VScan Rapid Test Kits for HIV and TB into several countries in South America to begin regulatory testing. Medical Services is pleased to announce that the ini
Schering-Plough Reports Novel Investigational Protease Inhibitor Shows In Vitro Antiviral Activity in Hepatitis C Infection: PRNewswire - October 24, 2003; BOSTON, Oct. 24 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today reported that a novel investigational protease inhibitor developed by Schering-Plough Research Institute (SPRI) was shown to be a potent inhibitor of hepatitis C virus (HCV) replication in vitro, according to data provided by resear
AHF commends Clinton for deal on ARVs: AIDS treatment falls to US$139: PRNewswire - October 23, 2003; Los Angeles, October 23/PRNewswire/ -- AIDS Healthcare Foundation (AHF), The US largest AIDS organisation, hailed today s Clinton Foundation announcement of a breakthrough in HIV drug pricing as a watershed achievement with the potential to save literally millions of lives. AIDS Healthcare Foundation President Michael
Visual AIDS Unveils Winners of National Art Competition to Raise Awareness of CMV Retinitis: PRNewswire - October 22, 2003; -- Exhibition of Prize Winning Works Opens at Artists Space October 22 - November 1, 2003 NEW YORK, Oct. 22 /PRNewswire/ -- Visual AIDS today announced the winners of the Share Your Vision national art competition, the goal of which was to raise awareness of CMV retinitis. The art contest and exhibition were a yea
Panacos Pharmaceuticals Publishes Major Study Describing the Unique Mechanism of Action of its Lead HIV Drug Candidate, PA-457: PRNewswire - October 21, 2003; -- PA-457 is the First in a New Class of Antiretrovirals Called Maturation Inhibitors GAITHERSBURG, Md., Oct. 21 /PRNewswire/ -- Panacos Pharmaceuticals today announced the publication of a study elucidating the mechanism of action of its lead drug candidate, PA-457, in development for the treatment of Human Immunodefi
FDA Approves New Protease Inhibitor, Lexiva(TM), the Only Protease Inhibitor to Offer Flexible Dosing with No Food or Water Restrictions: PRNewswire - October 21, 2003; CAMBRIDGE, Mass., Oct. 21 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the Food and Drug Administration ( FDA ) has granted marketing clearance for Lexiva(TM) ( fosamprenavir calcium) (Lex-ee -va, formerly GW433908, or 908), a new protease inhibitor (PI) for the tre
AIDS Healthcare Foundation Tells CalPERS: Sell $850M Stake in Glaxo After Guilty Verdict in South Africa: PRNewswire - October 21, 2003; LOS ANGELES, Oct. 21 /PRNewswire/ -- In a stunning rebuke of GlaxoSmithKline Plc (GSK), South Africa s Competition Commission, the country s corporate watchdog organization, found that GSK violated South African law by charging excessive prices for its HIV drugs in South Africa and illegally interfering in the market f
Theratechnologies: ThGRF a potential treatment for patients with wasting associated with COPD: Phase II clinical results support move into late-stage development: PRNewswire - October 21, 2003; MONTREAL, Oct. 21 /PRNewswire-FirstCall/ - Theratechnologies (TSX: TH) today announced preliminary results for a Phase II study testing ThGRF, its growth hormone-releasing factor analogue, in patients suffering from chronic wasting, or muscle depletion, secondary to chronic obstructive pulmonary disease (COPD). Highlig
Harvey Fierstein to Lead Public Forum on HIV Prevention in New York City's Gay Community: PRNewswire - October 20, 2003; -- Program Designed to Raise Awareness About the Current Scarcity of HIV Prevention Strategies and to Engage the Community in a Discussion on the Resurgence of HIV Infection Among Gay Men NEW YORK, Oct. 20 /PRNewswire/ -- Tony-Award winning actor and gay activist, Harvey Fierstein will headline a public forum on the ri
AlphaVax Announces New $16.8 Million NIH Award: PRNewswire - October 20, 2003; RESEARCH TRIANGLE PARK, N.C., Oct. 20 /PRNewswire/ -- AlphaVax, Inc. announced today that it has received notice of a new five-year, $16.8 million contract from the National Institute of Allergy and Infectious Disease (NIAID) of the National Institutes of Health (NIH), an agency of the U.S. Department of Health and Hum
Medical Services to Begin Live a Live Testing Program Using Whole Blood With The Red Cross in the People's Republic of China: PRNewswire - October 20, 2003; EDMONTON, Alberta, Oct. 20 /PRNewswire-FirstCall/ -- Medical Services International Inc. (Pinksheets: MSITF) is pleased to announce that it will immediately begin a live testing program with the Red Cross in the People s Republic of China . One of the programs will consist of testing pregnant women in an attempt to red
AIDS Healthcare Foundation Salutes Abbott Labs for Price Cuts on Key AIDS Drugs in Africa: Pharmaceutical Giant to Sell Norvir(R), Kaletra(TM), and Other Drugs 'At No Profit' in Africa and UN-determined 'Least Developed Countries': PRNewswire - October 20, 2003; LOS ANGELES, Oct. 20 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), the largest AIDS organization in the US and operator of free AIDS treatment clinics in the US, South Africa , Uganda and Honduras , today applauded Abbott Laboratories recently-announced
Gay & Lesbian Elder Housing, Eric Garcetti & McCormack Baron Salazar Announce Affordable Housing Development for Gay, Lesbian, Bisexual, Transgender (GLBT) Elders in Hollywood - First in the U.S.: PRNewswire - October 20, 2003; -- 103 Unit Building With Older Adult Recreational and Social Services Center Is First Ever for GLBT Community HOLLYWOOD, Calif., Oct. 20 /PRNewswire/ -- Los Angeles City Councilmember Eric Garcetti (13th District), Brian M. Neimark, Executive Director of Gay & Lesbian Elder Housing (GLEH) and Mercedes Marquez, Vic
AIDS Healthcare Foundation Lauds GSK for Latest Price Cut on Combivir, Urges Fast-track Action on Voluntary Licensing: PRNewswire - October 19, 2003; -- US Largest AIDS Group Acknowledges British Drug Giant for Latest Price Cut on Key AIDS Drug, Demands Fast Action on Voluntary Licensing Following GSK s Stunning Rebuke by South Africa s Competition Commission LOS ANGELES, Oct. 19 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), the largest AIDS organization in the
Calypte's Urine Based HIV Test Receives Approval in the Republic of Kenya: PRNewswire - October 17, 2003; ALAMEDA, Calif., Oct. 17 /PRNewswire-FirstCall/ -- Calypte Biomedical Corporation (OTC Bulletin Board: CYPT), the developer and marketer of the only two FDA approved HIV-1 antibody tests that can be used on urine samples, as well as an FDA approved serum HIV-1 antibody Western blot supplemental test, announced that the
New Research Relationships, Financing, and Business Strategy All Enhance Opportunities for CytRx, CEO Tells Annual Meeting: PRNewswire - October 17, 2003; -- CytRx Now Focusing Most Efforts on Breakthrough Drug Products that Meet Major Market Needs, Using Leading Edge Gene Silencing Technology, He Says LOS ANGELES, Oct. 17 /PRNewswire-FirstCall/ -- CytRx Corporation (Nasdaq: CYTR) has successfully re-focused the company s business and financial strategy, positioning us f
GlaxoSmithKline Takes Further Action to Help the World's Poorest Fight HIV/AIDS - Combivir Down to 65 Cents Per Day; Extensions to South Africa Voluntary License: PRNewswire - October 16, 2003; LONDON and PHILADELPHIA, Oct. 16 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) ( GSK ) today announced further action to help the world s poorest countries meet the unique challenges of HIV/AIDS. In keeping with its commitment to pass on cost savings in the manufacture of antiretrovirals (ARVs), the company has
Calypte Biomedical Corporation and LabOne Sign Multi-Year Agreement: Agreement Insures Urine HIV Testing Availability for the Life Insurance Industry: PRNewswire - October 16, 2003; ALAMEDA, Calif., Oct. 16 /PRNewswire-FirstCall/ -- Calypte Biomedical Corporation (OTC Bulletin Board: CYPT), the developer and marketer of the only two FDA approved HIV-1 antibody tests for use with urine samples, announced today that the Company has signed a multi-year agreement with LabOne, Inc., Lenexa, Kan., for t
A Monumental Decade for Combating Illness and Disease; Compelling Evidence on the Value of Research-Based Pharmaceutical Medicines: PRNewswire - October 16, 2003; WASHINGTON, Oct. 16 /PRNewswire/ -- Over 300 new drugs, biologics and vaccines have been approved over the past 10 years to prevent and treat over 150 conditions, according to a major new report by the Pharmaceutical Research and Manufacturers of America (PhRMA). The report, titled A Decade of Innovation, describes how
T-Boz and Chilli of TLC Urge Latinos to Get the Facts About HIV on First National Latino AIDS Awareness Day: PRNewswire - October 15, 2003; NEW YORK, Oct. 15 /PRNewswire/ -- Hip Hop SuperStars Tionne T-Boz Watkins and Rozonda Chilli Thomas of TLC launch Dialogues: Education and Treatment for a Well Planned Future -- a national education initiative to help patients get the facts about HIV and get involved in their care -- in Spanish today on the first-ever
Pennsylvania Department of Public Welfare: Special Pharmaceutical Benefits Program Adds Two HIV Drugs to Benefit Pennsylvanians: PRNewswire - October 15, 2003; HARRISBURG, Pa., Oct. 15 /PRNewswire/ -- Pennsylvania Public Welfare Secretary Estelle B. Richman today announced the addition of Emtriva (emtricitabine) and Reyataz ( atazanavir sulfate) for the treatment of HIV/AIDS to the Special Pharmaceutical Benefits Program (SPBP).
Medical Services to Participate in Live Testing With the Military in the People's Republic of China: PRNewswire - October 15, 2003; EDMONTON, Alberta, Oct. 15 /PRNewswire-FirstCall/ -- Medical Services International Inc., (Pinksheets: MSITF) is pleased to announce that it has agreed to participate in a live testing program with a military hospital in the northern military district of the People s Republic of China . The live testing program will i
E Education Network Sponsors African Center Foundation's 3rd Africa Sons Awards at the United Nations - Education for Africa HIV/AIDS Problem a Major Focus: PRNewswire - October 15, 2003; NEW YORK, Oct. 15 /PRNewswire/ -- E Education Network, Inc. a subsidiary of Exus Global, Inc. (OTC Bulletin Board: EXGL) sponsored the African Center Foundation s awards on October 9, 2003 at the United Nations. The awards -- 3rd Sons of Africa honored the following individuals for their efforts and contributions to Af
Xilinx Champions Silicon Valley Walk for AIDS: Company extends 12-year commitment to the fight against AIDS with Red Ribbon sponsorship: PRNewswire - October 15, 2003; SAN JOSE, Calif., Oct. 15 /PRNewswire/ -- In keeping with a strong culture of community volunteerism, Xilinx, Inc. (Nasdaq: XLNX), today announced it is once again the Red Ribbon Sponsor for the Silicon Valley Walk for AIDS. As a major sponsor of this local event, Xilinx will have a team of approximately 200 walkers on
Amarillo Biosciences Files Investigational New Drug (IND) Application to Test Oral Interferon Alpha in Oral Warts in HIV-Positive Subjects: PRNewswire - October 14, 2003; AMARILLO, Texas, Oct. 14 /PRNewswire-FirstCall/ -- Amarillo Biosciences, Inc. (OTC Bulletin Board: AMAR) (ABI) today announced filing of an IND application for a pivotal Phase III trial to test low-dose interferon alpha lozenges administered orally to human immunodeficiency virus (HIV)-positive subjects with oral warts
White House Pushes Global AIDS Fund into Crisis: PRNewswire - October 14, 2003; WASHINGTON, Oct. 14 /PRNewswire/ -- The future of a collaborative, multilateral response to AIDS, Tb and malaria now hangs in the balance, the Global AIDS Alliance said today. Thanks to the White House preference for a US-go-it-alone strategy, the Global Fund to Fight AIDS, Tb and Malaria now faces a battle for surviva
The N Partners With National PTA and the Henry J. Kaiser Family Foundation to Present a Special Episode of the Teen Series 'A Walk In Your Shoes - Living With HIV/AIDS' on Monday, December 1, at 9:30 pm (ET) in Support of World AIDS Day: PRNewswire - October 13, 2003; -- New PSA Campaign Targeting Teens to Kick off The N s Contribution to The Viacom/Kaiser Partnership KNOW HIV/AIDS -- Parent Discussion Guide to Be Distributed to 26,000 PTA Leaders Nationwide NEW YORK, Oct. 13 /PRNewswire/ -- The N, the nighttime network for teens, is partnering with National PTA and the Henry J. Kai
17th Annual AIDSWalkPhilly 2003: Philadelphia's First Walk: PRNewswire - October 13, 2003; PHILADELPHIA, Oct. 13 /PRNewswire/ -- The 17th Annual AIDSWalkPhilly 2003 is set for 10:00 a.m. Sunday, October 19th, and begins and ends in front of the Art Museum steps. At a time when many other charities have embraced pledge-a-thons as a fundraising tool, it all started with AIDSWalkPhilly, the first walk-a-thon pr
California's Largest AIDS Organization Denounces State AIDS Cut: PRNewswire - October 10, 2003; -- AIDS Healthcare Foundation Slams State Bureaucrats Who Eviscerate HIV Medical Funding While Claiming Opposite: California Conference of Local AIDS Directors (CCLAD), L.A. County s Office of AIDS (OAPP) Director, Also Oppose Whopping $7M cut from $8M Medical Testing Program LOS ANGELES, Oct. 10 /PRNewswire/ -- Denoun
Latino Leaders Respond to HIV/AIDS State of Emergency in the Hispanic Community: Coalition Formed to Celebrate First National Latino AIDS Awareness Day: PRNewswire - October 10, 2003; NEW YORK and LOS ANGELES, Oct. 10 /PRNewswire/ -- There is a health crisis in the Latino community that is being ignored. Despite all of the education and outreach funded to prevent HIV infection, very little of the information has found its way to the Latino community. As a response to this crisis over 100 cities nati
The Immune Response Corporation Licenses Hybridon's 2nd-Generation CpG DNA Adjuvant, AMPLIVAX(TM), for Use in Development of a Novel Vaccine for the Prevention and Treatment of HIV: PRNewswire - October 9, 2003; CARLSBAD, Calif. and CAMBRIDGE, Mass., Oct. 9 /PRNewswire-FirstCall/ -- The Immune Response Corporation (Nasdaq: IMNR) and Hybridon, Inc. (OTC Bulletin Board: HYBN) today announced that they have entered into a license agreement for the use of AMPLIVAX(TM) as an adjuvant in the development of a novel vaccine candidate
Calypte Receives Initial Order From Botswana: Mistaire LLC Appointed Non-Exclusive Distributor For Botswana: PRNewswire - October 9, 2003; ALAMEDA, Calif., Oct. 9 /PRNewswire-FirstCall/ -- Calypte Biomedical Corporation (OTC Bulletin Board: CYPT), the developer and marketer of the only two FDA approved HIV-1 antibody tests that can be used on urine samples, as well as an FDA approved serum HIV-1 antibody Western blot supplemental test, announced that it h
FDA Grants Tanox's Anti-CD4 Drug Fast Track Status for the Treatment of HIV-1: PRNewswire - October 9, 2003; HOUSTON, Oct. 9 /PRNewswire-FirstCall/ -- Tanox, Inc. (Nasdaq: TNOX) announced today that the U.S. Food and Drug Administration ( FDA ) has granted fast track status to TNX-355 for the treatment of patients with human immunodeficiency virus 1 (HIV-1) infection who have failed or are failing antiretroviral therapy. Und
Latino Leaders Join Forces to Commemorate First National Latino AIDS Awareness Day: PRNewswire - October 9, 2003; NEW YORK, Oct. 9 /PRNewswire/ -- On October 15 in over 100 cities around the country Latinos will join together to mark the First Annual Latino AIDS Awareness Day and to call on Health and Human Services Secretary Tommy Thompson to expand HIV prevention efforts in all segments of the Latino community. In cities from An
Medical Services to Supply HMO in the People's Republic of China: PRNewswire - October 9, 2003; EDMONTON, Alberta, Oct. 9 /PRNewswire-FirstCall/ -- Medical Services International Inc. (Pinksheets: MSITF) is pleased to announce that it has received a letter of intent from a major Chinese Health Management Organization (HMO) representing 16 hospitals in 6 provinces in the People s Republic of China , t
Calypte Completes China Clinical Trials: HIV-1 Urine EIA Trial Results Submitted to State Drug Administration For Approval By Biologics Branch: PRNewswire - October 8, 2003; ALAMEDA, Calif., Oct. 8 /PRNewswire-FirstCall/ -- Calypte Biomedical Corporation (OTC Bulletin Board: CYPT), the developer and marketer of the only two FDA approved HIV-1 antibody tests that can be used on urine samples, as well as an FDA approved serum HIV-1 antibody Western blot supplemental test, announced that it h
BioVex Receives Notice of Allowance From the US PTO For Core Patent Covering Its Immunovex Vaccine Platform: PRNewswire - October 8, 2003; OXFORD, England, Oct. 8 /PRNewswire/ -- BioVex Limited announced today that it had received a Notice of Allowance from the US Patent and Trademark Office in relation to one of its core patents. The patent relates to the use of HSV as a platform for antigen delivery for vaccine purposes and covers both direct in vivo an
UNA-USA Honors Leaders in The Global Fight Against HIV/AIDS; U2's Bono to Speak About His Work in Africa: PRNewswire - October 7, 2003; WHO: *** Bono, Lead Singer, U2 (Special Guest) *** Tommy Thompson, Secretary of Health and Human Services (Keynote Speaker) *** Henry A. McKinnell, Chairman and Chief Executive Officer, Pfizer Inc, (2003 Global Leadership Award Honoree) *** Dr. Alex Godwin Coutinho, Executive Director, The AIDS Support Organizati
Treatment Action Campaign in South Africa Receives Mandela Health & Human Rights Award: PRNewswire - October 6, 2003; -- Internationally Recognized Leader in Fight for Treatment and Health Equity Cited for Work in South Africa and Internationally MENLO PARK, Calif., Oct. 6 /PRNewswire/ -- The Treatment Action Campaign (TAC), a Cape Town, South Africa-based HIV/AIDS treatment advocacy group, received the Nelson Mandela Award for Health
AIDS Healthcare Foundation on GSK: Those Who Can, Invent; Those Who Can't, Market: British Drug Giant's Marketing Triumphs Over New Drug Development -- GSK's Contribution to AIDS Science Questioned: PRNewswire - October 6, 2003; LOS ANGELES, Oct. 06 /PRNewswire/ -- A New York Times article in Sunday s Business section examining the impact that repeated corporate mergers have had on new drug development at British drug giant GlaxoSmithKline plc (GSK) has reinforced AIDS advocates ongoing assertions that GSK -- which controls approximately 40% o
Generex Biotechnology Announces Publication of Scientific Paper Highlighting Pre-Clinical Results of HIV Peptide Vaccine: PRNewswire - October 2, 2003; TORONTO, Oct. 2 /PRNewswire-FirstCall/ -- Generex Biotechnology Corporation today announced publication of a scientific paper from its Antigen Express immunomedicine subsidiary reporting progress in developing a novel peptide vaccine for HIV. The paper, Ii-Key MHC class II epitope hybrid peptide vaccines for HIV , is p
Biosyn, Inc. Receives up to $10 Million for the Development of a Novel HIV Fusion Inhibitor: PRNewswire - October 2, 2003; HUNTINGDON VALLEY, Pa., Oct. 2 /PRNewswire/ -- Biosyn, Inc. announced today that the International Partnership for Microbicides (IPM) has agreed to provide up to $10 million in milestone-driven funding over the next four years for the advancement of cyanovirin-N (CV-N), a novel fusion inhibitor in development for the p
ADVENTRX Pharmaceuticals Expands Preclinical Testing of Second Generation HIV Viral Entry Inhibitor: BlockAide/VP(TM) Disrupts HIV Binding to Immune System Cells: PRNewswire - October 2, 2003; SAN DIEGO, Oct. 2 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. announced today that it has expanded its internal development efforts for BlockAide/VP, a viral entry inhibitor for treatment of HIV/AIDS. We are studying BlockAide/VP in a series of viral inhibition assays to further document the in vitro poten
Calypte Biomedical Corporation Plans New Initiative With The AIDS Action Council In Africa: PRNewswire - October 1, 2003; ALAMEDA, Calif., Oct. 1 /PRNewswire-FirstCall/ -- Calypte Biomedical Corporation (OTC Bulletin Board: CYPT.OB) announced their participation in a new initiative with the AIDS Action Council to accelerate the accessibility of rapid HIV testing in Africa. The initiative will begin with a five-country tour of Africa --
VIRxSYS Granted Patent for Using HIV-based Lentiviral Vectors to Efficiently Deliver Therapeutic Genes into Hematopoietic Cells: PRNewswire - October 1, 2003; GAITHERSBURG, Md., Oct. 1 /PRNewswire/ -- VIRxSYS Corporation, a private biotechnology company focused on the development of genetic medicines for the treatment of serious diseases such as HIV/AIDS, announced today that it was issued US patent 6,627,442 from the United States Patent and Trademark Office entitled, Meth
UNA-USA Honors Leaders in the Global Fight Against HIV/AIDS: U2's Bono to Speak to About His Work in Africa: PRNewswire - October 1, 2003; NEW YORK, Oct. 1 /PRNewswire/ -- The United Nations Association of the USA (UNA-USA) and the Business Council for the U.N. (BCUN) will present their 2003 Global Leadership and Humanitarian Action Awards on October 8 in New York City. Special guests for the Awards Ceremony will be Secretary-General Kofi Annan, U.S. Secr
AIDS Healthcare Foundation Sues the United States Health Resources & Services Administration: H.R.S.A. Hit With Freedom of Information Lawsuit Over Access To AIDS Funding Documents: PRNewswire - September 30, 2003; -- Nation s Largest AIDS Group Files Suit Against Government Agency After Repeated Unsuccessful Attempts to Obtain Records On Federal Arm of Ryan White Funding Process LOS ANGELES, Sept. 30 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), the largest AIDS organization in the United States , has filed a Freedom of I
PR Newswire Named Official Newswire for National Latino AIDS Awareness Day 2003: PRNewswire - September 30, 2003; NEW YORK, Sept 30 /PRNewswire/ -- The Hispanic Federation and the Latino Commission on AIDS have chosen PR Newswire as the official newswire for National Latino AIDS Awareness Day (NLAAD) 2003, the organizations announced today. As the official newswire, PR Newswire will distribute all the news releases relating to thi
The Immune Response Corporation Initiates Phase II Study of REMUNE(R) With HIV-Infected Patients in Italy: PRNewswire - September 29, 2003; CARLSBAD, Calif., Sept. 29 /PRNewswire-FirstCall/ -- The Immune Response Corporation (Nasdaq: IMNR) today announced the initiation of a Phase II clinical study designed to evaluate the use of REMUNE(R), an immune-based therapeutic vaccine, for treatment of HIV-infected patients who have not been treated previously with
Epimmune Awarded $16.7 Million National Institutes of Health Contract For HIV Vaccine Development: PRNewswire - September 29, 2003; SAN DIEGO, Sept. 29 /PRNewswire-FirstCall/ -- Epimmune Inc. (Nasdaq: EPMN) today announced that it has received a five-year, $16.7 million contract from the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH), an agency of the U.S. Department of Health and Human Serv
Novavax Selected by NIAID/NIH to Develop HIV Vaccine: $19.0 Million Contract Demonstrates Potential of Company's VLP Platform Technology: PRNewswire - September 29, 2003; COLUMBIA, Md., Sept. 29 /PRNewswire-FirstCall/ -- NOVAVAX, INC. (Nasdaq: NVAX) today announced that it was awarded a five year $19.0 million contract [NO1-AI-30042] from the National Institute of Allergy and Infectious Diseases (NIAID) for the design and development of a new class of human immunodeficiency virus (HIV)
Joint Statement Between The United States of America and the Russian Federation: PRNewswire - September 27, 2003; WASHINGTON, Sept. 27 /PRNewswire/ -- President George W. Bush and President Vladimir V. Putin held productive discussions at Camp David, Maryland, on September 26 and 27, 2003. Building on the Joint Declaration on the New Strategic Relationship of May 24, 2002, and other joint documents, they focused on practical ways
Calypte Biomedical to Test its Urine Based HIV-1 Test in Tanzania, Rwanda, Burundi and Botswana: PRNewswire - September 24, 2003; ALAMEDA, Calif., Sept. 24 /PRNewswire-FirstCall/ -- Calypte Biomedical Corporation (OTC Bulletin Board: CYPT), the developer and marketer of the only two FDA approved HIV-1 antibody tests that can be used on urine samples, as well as an FDA approved serum HIV-1 antibody Western blot supplemental test announced today th
Abbott Laboratories and Boehringer Ingelheim Donate Test Kit and AIDS Drug to Help Prevent Mother-to-Child Transmission of HIV: PRNewswire - September 23, 2003; ABBOTT PARK, Ill. and INGELHEIM, Germany , Sept. 23 /PRNewswire/ -- Abbott Laboratories and Boehringer Ingelheim announced today a cooperative arrangement that will help prevent the transmission of the HIV virus from mother to child (Prevention of Mother To Child Transmission, PMTCT) in the d
ADVENTRX Pharmaceuticals Expands HIV Antiviral Platform through Development Of Thiovir(TM): Preclinical data suggest viral inhibitor could play a key role in HAART: PRNewswire - September 23, 2003; SAN DIEGO, Sept. 23 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (OTC Bulletin Board: AVRX) announced today that it has accelerated internal development efforts for Thiovir, an NNRTI (non-nucleoside reverse transcriptase inhibitor) for treatment of HIV/AIDS. Thiovir is an oral prodrug for foscarnet, which i
Research Grants Totaling $5.7 Million Awarded for Evaluation of Guilford Pharmaceuticals' Technologies: PRNewswire - September 23, 2003; BALTIMORE, Sept. 23 /PRNewswire-FirstCall/ -- Guilford Pharmaceuticals Inc. (Nasdaq: GLFD) announced today that grants totaling approximately $5.7 million have been awarded for research and development of the Company s technologies. These include a $5.5 million award by the National Institutes of Health to support a fo
Modernized Hospital Will Improve HIV/AIDS Care In Tanzania: PRNewswire - September 22, 2003; -- Multi-year, multi-million dollar initiative will help create a sustainable health care infrastructure that will provide enhanced care and services to people living with HIV/AIDS - ABBOTT PARK, Ill. and NAIROBI, Kenya , Sept. 22 /PRNewswire-FirstCall/ -- For the estimated two million Tanzanians living with HIV/AIDS,
Report Gives Nigerian President Obasanjo High Marks in Fight against AIDS: PRNewswire - September 22, 2003; NEW YORK, Sept. 22 /PRNewswire/ -- An independent analysis by Global AIDS Alliance, released as the UN General Assembly convenes a special session on HIV/AIDS, shows that Nigeria , under the leadership of President Olusegun Obasanjo, is making a significant contribution to the fight against HIV/AIDS. He has taken
E Education Network Invited to African Center Foundation's 3rd Sons of Africa Awards at the United Nations: PRNewswire - September 22, 2003; NEW YORK, Sept. 22 /PRNewswire-FirstCall/ -- E Education Network, Inc. a subsidiary of Exus Global, Inc. (OTC Bulletin Board: EXGLV) today announced that it plans to participate in the African Center Foundation s 3rd Sons of Africa Awards on October 9th, 2003, to be held at the United Nations. The dinner will honor the
Uganda Battles Disease Through Wireless Health Care Infrastructure: PRNewswire - September 22, 2003; -- Nationwide Network Brings Data Connectivity, Information to Remote Health Facilities and Workers BOSTON, Sept. 22 /PRNewswire/ -- SATELLIFE, a non-profit organization focused on improving health in developing countries, WideRay, an enabler of proximity wireless data services, and Canada s International Development R
Boosted Saquinavir Shows Significant Safety Benefit Over Boosted: Crixivan(R) in Large Head-to Head Study of HIV Protease Inhibitors - Study Results Published in The Journal of Infectious Diseases: PRNewswire - September 19, 2003; NUTLEY, N.J., Sept. 19 /PRNewswire/ -- Clinical study results published in the Sept. 1 issue of The Journal of Infectious Diseases show that boosted saquinavir (saquinavir 1000 mg with ritonavir 100 mg) reduced HIV to undetectable levels in significantly more patients than boosted
Significant Response Seen with Boosted Saquinavir at Almost One Year In Protease Inhibitor-Experienced HIV Patients - Data also examines variables affecting response rate in treatment-experienced patients -: PRNewswire - September 17, 2003; CHICAGO, Sept. 17 /PRNewswire/ -- New data presented today indicate that more than two-thirds of treatment-experienced HIV patients who received boosted saquinavir (saquinavir 1000 mg with ritonavir 100 mg twice-daily) and completed the 48-week treatment period (n=85) experienced a significant viral response. Viral re
The Immune Response Corporation Continues to Expand Its HIV/AIDS Expertise With the Appointment of Peter L. Salk, M.D., to Its Scientific Advisory Board: PRNewswire - September 17, 2003; CARLSBAD, Calif., Sept. 17 /PRNewswire-FirstCall/ -- The Immune Response Corporation (Nasdaq: IMNR) today announced the appointment of Peter L. Salk, M.D., to its Scientific Advisory Board as part of the company s continuing expansion of its HIV/AIDS expertise. The Scientific Advisory Board was established recently to
Pharmacokinetic Data Presented at ICAAC on Investigational HIV Protease Inhibitor 433908 (908) Suggest It Can Be Taken With Maalox TC, Zantac, or Lipitor: PRNewswire - September 16, 2003; At A Glance -- These PK data suggest that 908 can be co-administered without dose adjustments or dose separation with Maalox TC or Zantac (antacids) by HIV/AIDS patients suffering from heartburn or other gastrointestinal problems. -- Co-administration of 908 with Lipitor (ATO) did not significantly affect the PK of
UCLA Study Demonstrates Utility of ViroLogic Co-Receptor Tropism And Replication Capacity Assays as Predictors of HIV Progression: PRNewswire - September 16, 2003; CHICAGO, Sept. 16 /PRNewswire-FirstCall/ -- ViroLogic, Inc. (Nasdaq: VLGC) today announced the presentation of data demonstrating the utility of HIV Co-Receptor Tropism and Replication Capacity, a gauge of viral fitness, as predictors of clinical progression to AIDS. The study was featured in the late breaker session a
Study Assessing Once Daily Abacavir (ABC) in a Once Daily ART Regimen Presented at ICAAC: PRNewswire - September 16, 2003; At a Glance -- A large double-blind study comparing a once-daily (QD) and twice-daily (BID) regimen of ABC, each in combination with 3TC QD and EFV QD showed the QD regimen to be non-inferior to the BID regimen. -- The QD combination of 3TC, ABC and EFV could be a true once-a-day regimen with patients being able
Interim Analysis Comparing Tenofovir (TDF) to Efavirenz (EFV) in combination With Lamivudine (3TC) + Abacavir (ABC) Reports High Rate of Virologic Non-Response in TDF Arm: PRNewswire - September 16, 2003; At a Glance -- In a study comparing TDF vs. EFV (both given with 3TC and ABC), 49 percent of patients in the TDF arm experienced early virologic non-response, compared with 5 percent of patients in the EFV arm at week 8. -- 90 percent of patients in the EFV arm achieved viral loads
Primagen Earns ISO 9001:2000 Certification: PRNewswire - September 16, 2003; AMSTERDAM, Netherlands , Sept. 16 /PRNewswire/ -- Primagen Holding B.V. (http://www.primagen.com), a provider of molecular diagnostic tests for infectious diseases, AIDS and cancer, announced today it has earned full ISO 9001:2000 certification. ISO (International Organization for Standardization) is the source of the
ADVENTRX Pharmaceuticals Raises $2.5 Million Through a Private Placement: Company to Use Funding for Clinical Trials and to Accelerate Pre-Clinical Development: PRNewswire - September 16, 2003; SAN DIEGO, Sept. 16 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. announced today that it has raised approximately $2.5 million through a private placement with institutional and accredited investors. The Company issued approximately 2.5 million shares of its unregistered common stock, with 30% warrant cover
Medical Services Introduces the VScan Test Kits Into South America: PRNewswire - September 16, 2003; EDMONTON, Alberta, Sept. 16 /PRNewswire-FirstCall/ -- Medical Services International Inc. (Pinksheets: MSITF) is pleased to announce that it has begun shipping the VScan rapid test kits for HIV and TB into several countries in South America to begin regulatory testing. The Company expects to have the initial testing co
Calypte Biomedical Receives Letter of Intent For $4 Million Purchase Order From World Vision Africa: PRNewswire - September 16, 2003; ALAMEDA, Calif., Sept. 16 /PRNewswire-FirstCall/ -- Calypte Biomedical Corporation (OTC Bulletin Board: CYPT), the developer and marketer of the only two FDA approved HIV-1 antibody tests that can be used on urine samples, as well as an FDA approved serum HIV-1 antibody Western blot supplemental test announced today th
New Partnership Between Government, Industry and Academia to Expand Access to HIV Treatment in Cambodia: 'Cambodia Treatment Access Project' to provide HIV Care, Research, and Training: PRNewswire - September 16, 2003; NUTLEY, N.J., Sept. 16 /PRNewswire/ -- Three partners: the Cambodian Ministry of Health, National Centre in HIV Epidemiology and Clinical Research at the University of New South Wales and Roche announce the launch of the Cambodia Treatment Access Project (CTAP), which endeavors to widen access to sustainable HIV health
Survey Shows that Nearly 80 Percent of Physicians Believe That HIV Patients Taking Antiretroviral Drugs Are at an Increased Cardiovascular: Smoking, Antiretroviral Use and Family History Cited as Primary Reasons Risk: PRNewswire - September 16, 2003; CHICAGO, Sept. 16 /PRNewswire/ -- Nearly 80 percent of surveyed physicians say that HIV- positive patients receiving antiretroviral treatment are at an increased risk for cardiovascular complications, according to results from physician and patient surveys released today in a supplement to the peer-reviewed journal JIA
Nickelodeon and The Elizabeth Glaser Pediatric AIDS Foundation to Partner for High Fashion 'Designer SquarePants' Fundraising Initiative: PRNewswire - September 15, 2003; SpongeBob-Inspired Pants Created by Top Designers to Be Showcased Sept. 20 at Kids for Kids Celebrity Carnival; Pants to be Up for Bid on eBay Sept. 19-30 Giorgio Armani, Donna Karan, Sean John, Diane von Furstenberg, Oscar de la Renta, Carolina Herrera Among 16 Top Designers Enlisted to Create SpongeBob-Inspired Pants
GSK Reneges on Lower AIDS Drug Prices for Africa: PRNewswire - September 15, 2003; Widespread Price Discrepancies Prevent Ugandans Access to Life-Saving ARVS: Uganda to Pay Almost $48USD Per Month for Key GSK Drug Combivir , While South Africa Pays Only $27USD. British Drug Giant s Pricing Policies Limit Drug Access in African Country Poised to Continue as Leader in Fight Against AIDS.
Follow-up Data Confirms Safety and Efficacy of Nelfinavir In Patients Co-Infected With Hepatitis C: PRNewswire - September 15, 2003; CHICAGO, Sept. 15 /PRNewswire/ -- Management of HIV/Hepatitis C (HCV) co-infected patients is a burgeoning problem. End stage liver disease is now recognized as a leading cause of death in HIV-infected persons, especially in those taking HAART therapy. With the prevalence of co-infection ranging from 30 to 40 percent o
2NN Sub-Study Finds HIV Treatment Regimens Containing VIRAMUNE(R) or Efavirenz Demonstrate a Comparable Viral Decay Rate: Findings Presented at the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy in Chicago: PRNewswire - September 15, 2003; CHICAGO, Sept. 15 /PRNewswire/ -- A sub-study of the landmark 2NN trial found that HIV treatment regimens containing either VIRAMUNE(R) ( nevirapine ) or efavirenz provide a comparable viral decay rate (VDR) over the first two weeks of treatment. The VDR measures the decline in viral load concentration after the start
First African Methodist Episcopal Church of Los Angeles Joins Pfizer Inc To Host 'Fighting HIV Through R&B', a Nationwide HIV Testing Initiative Offering Free R&B Tickets: PRNewswire - September 15, 2003; NEW YORK, Sept. 15 /PRNewswire/ -- First African Methodist Episcopal Church of Los Angeles (FAME), the oldest black congregation in the city of Los Angeles, has joined forces with pharmaceutical giant, Pfizer Inc, to host Fighting HIV through R&B , a novel HIV testing program that offers free R&B concert ticket
Kaletra-Based Regimen Demonstrated Viral Suppression for Patients New To Therapy in Five-Year HIV Trial: PRNewswire - September 15, 2003; CHICAGO, Sept. 15 /PRNewswire-FirstCall/ -- Study data presented today showed the majority of patients initiating therapy with Abbott Laboratories protease inhibitor (PI), Kaletra (R) ( lopinavir / ritonavir ), as part of their treatment regimen ach
New Data Show FUZEON-Based Regimens Continue to Provide Significant Durable Response in Treatment-Experienced HIV Patients Through 48 Weeks -- Reimbursement Progress and Increased Supply Diminish Early Concerns About Limited Access to FUZEON: PRNewswire - September 15, 2003; CHICAGO, Sept. 15 /PRNewswire-FirstCall/ -- Eighty percent of patients receiving a FUZEON(R) ( enfuvirtide )-based anti-HIV drug regimen who achieved undetectable levels of the virus at 24 weeks maintained this response at 48 weeks, according to new data presented today at the 43rd Interscience Conference on Antimicrob
Agouron/Pfizer Offers Wallet-Sized Guide to Healthy Meal Planning for People With HIV Using Viracept(R) - Taking Viracept with Properly Planned Meals Can Boost Drug Levels Up To Five Fold: PRNewswire - September 14, 2003; CHICAGO, Sept. 14 /PRNewswire-FirstCall/ -- To help people infected with human immunodeficiency virus (HIV) being treated with Viracept (R), Agouron Pharmaceuticals, Inc., a Pfizer Company (NYSE: PFE), is making available the Viracept On-the-Go wallet-sized meal planning gu
Study Evaluates Abacavir (ABC), Lamivudine (3TC) and Efavirenz (EFV) Versus Zidovudine (ZDV), Lamivudine (3TC) and Efavirenz in Treatment-Naive Patients: PRNewswire - September 14, 2003; At a Glance: -- In this study, combination therapy with 3TC /ABC/EFV was shown to be non-inferior to ZDV/3TC/EFV. -- 70 percent of subjects in the 3TC/ABC/EFV group and 69 percent of subjects in the ZDV/3TC/EFV group achieved viral load
ViroLogic Announces Presentations at the 43rd Interscience Conference On Antimicrobial Agents and Chemotherapy: PRNewswire - September 12, 2003; SOUTH SAN FRANCISCO, Calif., Sept. 12 /PRNewswire-FirstCall/ -- ViroLogic, Inc. (Nasdaq: VLGC) today announced that four presentations related to its novel drug resistance products and technology will be made at the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) scheduled to take place at
BET'S Rap-It-Up Brings Teen Forum to Baton Rouge And Naked Truth II Screening to New Orleans on September 18 - 19: PRNewswire - September 12, 2003; WASHINGTON, Sept. 12 /PRNewswire/ -- BET s Rap-It-Up campaign, an award- winning national HIV/AIDS public awareness initiative, visits Baton Rouge, Louisiana to host a local teen forum on Thursday, September 18 from 8:30 - 10:30 a.m. CT at Istrouma High School to discuss the rise of HIV/AIDS in the community and how it
New England Journal of Medicine Publishes New HIV/AIDS Study that Shows VIRAMUNE(R)- and Efavirenz-based Regimens Demonstrate Comparable Efficacy and Safety in Patients Switching from a Protease Inhibitor: PRNewswire - September 11, 2003; RIDGEFIELD, Conn., Sept. 11 /PRNewswire/ -- A study published today in The New England Journal of Medicine shows that treatment regimens containing VIRAMUNE(R) ( nevirapine ) or efavirenz offer comparable efficacy and safety in patients who switched from a protease inhibitor (PI)-based regimen. VIRAMUNE and efavirenz,
George Mason University Scientists Suggest Link Between Smallpox Vaccination and HIV Infection: PRNewswire - September 11, 2003; MANASSAS, Va., Sept. 11 /PRNewswire/ -- Researchers at George Mason University s National Center for Biodefense announce preliminary findings demonstrating that smallpox vaccination may confer a measurable degree of immunity to HIV infection. The evidence for protection against HIV was found in laboratory studies condu
Ugandan Government & AIDS Healthcare Foundation to Bring ARV Treatment To 10,000 Ugandans Living With HIV/AIDS: PRNewswire - September 10, 2003; -- New Partnership to Scale Up ARV Access in Uganda Includes Ministry of Health, Local African NGOs and US Largest AIDS Group: In July, Gilead Sciences , Inc. and AHF Global Immunity Announced Plan to Expand From 100 to 1,000 Patients On ARVs at Free AIDS Treatment Clinic in Masaka District -- AHF Global Immunity t
Updated AIDS Treatment Guidelines Recognize Growing Value and Importance of HIV Drug Resistance Testing: PRNewswire - September 9, 2003; -- Replication Capacity, Only Commercially Available from ViroLogic, Highlighted for First Time SOUTH SAN FRANCISCO, Calif., Sept. 9 /PRNewswire-FirstCall/ -- Recently updated guidelines from the International AIDS Society USA (IAS-USA) and the U.S. Department of Health and Human Services (DHHS) further support the val
Calypte's HIV-1 Antibody Tests Approved For Distribution in the Republic of Uganda: The Government of Uganda Has Announced that Urine Testing Is Approved For Distribution: PRNewswire - September 9, 2003; ALAMEDA, Calif., Sept. 9 /PRNewswire-FirstCall/ -- Calypte Biomedical Corporation (OTC Bulletin Board: CYPT), the developer and marketer of the only two FDA approved HIV-1 antibody tests that can be used on urine samples, as well as an FDA approved serum HIV-1 antibody Western blot supplemental test, announced that the
Medical Services Signs License Agreement for HIV Test Kit in the United States: PRNewswire - September 9, 2003; EDMONTON, Alberta, Sept. 9 /PRNewswire-FirstCall/ -- On July 1, 2003, Medical Services International Inc. (Pinksheets: MSITF) announced that the Company had begun the process with the appropriate regulatory agencies in the United States regarding the introduction and licensing of the Company s lead product the VScan HI
GSK Encourages Communities of Color to Take Charge of Their Health: 'Take A Loved One to the Doctor Day' September 16: PRNewswire - September 8, 2003; RESEARCH TRIANGLE PARK, N.C., Sept. 8 /PRNewswire/ -- This Tuesday, Sept. 16, GlaxoSmithKline , ABC Radio, and the Department of Health and Human Services (DHHS) are urging people of color to take charge of their well being and the well being of their loved ones by visiting a health professional during the third annual
Major Peer-Reviewed Journal Publication of a Clinical Study of THALOMID(R) Plus Temozolomide as Oral Regimen for Treating Patients with Advanced-Stage Metastatic Melanoma: PRNewswire - September 8, 2003; -- Objective of Clinical Trial to Determine Antitumor Response by Combining Immunomodulatory and Antiangiogenic Agents -- Overall Objective Response Rate of 32 Percent WARREN, N.J., Sept. 8 /PRNewswire-FirstCall/ -- Celgene Corporation (Nasdaq: CELG) today announced the results of a clinical study using THALOMID(R) in
Immtech Presents at the Interscience Conference on Antimicrobial Agents and Chemotherapy in Chicago September 14-17 - Recent advances of its dicationic drug development platform: PRNewswire - September 5, 2003; VERNON HILLS, Ill., Sept. 5 /PRNewswire-FirstCall/ -- Immtech International, Inc. (Amex: IMM) announced today that its scientists will present recent advances on both the in vitro and in vivo antifungal activity of the Company s dicationic drug development platform at the Interscience Conference on Antimicrobial Agents
Kaletra(R) Recommended by Department of Health and Human Services Panel As Part of Preferred Protease Inhibitor-Based Regimen for Initial Treatment Of HIV: PRNewswire - September 5, 2003; ABBOTT PARK, Ill., Sept. 5 /PRNewswire-FirstCall/ -- A panel convened by the U.S. Department of Health and Human Services (DHHS) has recommended Kaletra (R) ( lopinavir / ritonavir ), in combination with zidovudine or
'Faces of AIDS' and 'Heroes in the Struggle' Photo Exhibits Land at American Airlines LAX Terminal 4 on Monday: PRNewswire - September 5, 2003; -- Compelling Photo Exhibits to Be Viewed By Travelers at LAX T4, Sept. 8-11 -- National Photo Exhibit Tour Sponsored By American Airlines, JPMorgan Chase LOS ANGELES, Sept. 5 /PRNewswire/ -- American Airlines is making Los Angeles International Airport (LAX) the final stop on a four-city tour of Faces of AIDS - a Phot
Data Safety Monitoring Board Unanimously Recommends Continuation of VIRxSYS's Phase 1 Clinical Trial to Treat HIV-infected Patients: PRNewswire - September 4, 2003; GAITHERSBURG, Md., Sept. 4 /PRNewswire/ -- VIRxSYS Corporation, a private biotechnology company focused on the development of genetic medicines for the treatment of serious diseases such as HIV/AIDS, announced today that an independent Data Safety Monitoring Board (DSMB) has reviewed initial safety data for its first p
Biosyn, Inc. Initiates Phase I Clinical Testing of UC-781, a Novel HIV Microbicide: PRNewswire - September 4, 2003; HUNTINGDON VALLEY, Pa., Sept. 4 /PRNewswire/ -- Biosyn, Inc. announced today that enrollment has been initiated for a Phase I clinical trial for the investigational drug candidate, UC-781, as a microbicide for the prevention of sexually transmitted HIV. UC-781 is an HIV non-nucleoside reverse transcriptase inhibitor (N
AnorMED initiates Phase I trial for new anti-HIV drug candidate AMD070, a CXCR4 HIV entry inhibitor: PRNewswire - September 3, 2003; VANCOUVER, Sept. 3 /PRNewswire-FirstCall/ - AnorMED Inc. (TSX:AOM) announced today that it has initiated enrollment into a Phase I trial in healthy volunteers to evaluate the safety of AMD070 for the treatment of HIV infection. AMD070 targets the CXCR4 chemokine receptor and prevents HIV from entering and infecting hea
Epimmune Provides Update on Clinical Trials and Announces Workforce Reduction to Focus on Its Most Strategically Important Programs: PRNewswire - September 3, 2003; SAN DIEGO, Sept. 3 /PRNewswire-FirstCall/ -- Epimmune Inc. (Nasdaq: EPMN) today provided an update of its three ongoing clinical trials in HIV, lung cancer and colorectal cancer, and the Company announced a workforce reduction aimed at focusing its resources on the most advanced clinical programs and its sponsored and
The Well Project Implements the Documentum Enterprise Content Management Platform: HIV and AIDS Community-Based Organization for Women Relies on Documentum 5 to Manage Web Content: PRNewswire - September 3, 2003; PLEASANTON, Calif., Sept. 3 /PRNewswire-FirstCall/ -- Documentum (Nasdaq: DCTM), the leading provider of enterprise content management (ECM), today announced that The Well Project has implemented Documentum 5, the latest version of the Documentum ECM platform. The Well Project (TWP) is a community-focused organization
Dr. Susan B. Zolla-Pazner Joins Lipid Sciences' Viral Advisory Board: PRNewswire - September 3, 2003; PLEASANTON, Calif., Sept. 3 /PRNewswire-FirstCall/ -- Lipid Sciences, Inc. (Nasdaq: LIPD) announced today the appointment of Susan B. Zolla-Pazner, Ph.D., as a member of its Viral Advisory Board (VAB). Dr. Zolla-Pazner joins Dr. Aftab Ansari of Emory University and Dr. James E.K. Hildreth of Johns Hopkins University on
Landmark Survey Finds Majority of State's Schools in Violation of Confusing Sex Education Laws: PRNewswire - September 3, 2003; -- For a Copy of the Report Visit http://www.aclunc.org SACRAMENTO, Calif., Sept. 3 /PRNewswire/ -- The first statewide survey of sex education in California s public schools in almost a decade reveals that 85% of schools violate one or more laws governing this subject, and that the laws are confusing and inconsistent.
Female Health Company and Hindustan Latex Sign Agreement: FC Female Condom closer to marketing in India: PRNewswire - September 3, 2003; CHICAGO, Sept. 3 /PRNewswire-FirstCall/ -- The Female Health Company (OTC Bulletin Board: FHCO) today announced that it signed an agreement with Hindustan Latex Limited (HLL) appointing HLL as FHC s exclusive marketer and distributor in India . HLL is India s largest male condom manufacturer and also manufactures and m
The Well Project Launches New HIV/AIDS Website for Wom